Process for producing trans-4-hydroxy-L-proline

ABSTRACT

Provided is an industrially applicable process for producing trans-4-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into trans-4-hydroxy-L-proline in the presence of an enzyme source which is derived from a microorganism belonging to the genus Dactylosporangium, Amycolatopsis or Streptomyces and which catalyzes the hydroxylation of L-proline into trans-4-hydroxy-L-proline, a divalent iron ion and 2-ketoglutaric acid, in an aqueous medium, and the produced trans-4-hydroxy-L-proline is collected from the aqueous medium. Also provided is a novel enzyme L-proline-4-hydroxylase which is useful for the process, a gene of L-proline-4-hydroxylase which is useful for the process, a transformant containing the gene, and a process for producing L-proline-4-hydroxylase using the transformant. In addition, provided is a process for producing L-proline-4-hydroxylase using the transformant which contains the gene and has a reinforced proline biosynthesis activity.

This application is a divisional of Ser. No. 09/104,382, filed Jun. 25,1998 (now U.S. Pat. No. 6,242,231) which is a divisional of Ser. No.08/709,874, filed on Sep. 9, 1996 (now U.S. Pat. No. 5,854,040),which isa continuation-in-part of Ser. No. 08/482,554, filed Jun. 7, 1995 (nowabandoned), which is a continuation of Ser. No. 08/301,653 filed Sep. 7,1994 (now abandoned).

FIELD OF THE INVENTION

The present invention relates to a process for producingtrans-4-hydroxy-L-proline. Trans-4-hydroxy-L-proline is useful as astarting compound for medicines and an additive to foods. The presentinvention also relates to a novel enzyme capable of catalyzing thehydroxylation of L-proline at the 4-position of L-proline (hereinafterreferred to as L-proline-4-hydroxylase). The novel enzyme is used in theabove-mentioned process.

The present invention also relates to a process for industriallyproducing trans-4-hydroxy-L-proline, a gene encoding a protein having anactivity of L-proline-4-hydroxylase (hereinafter referred to as“L-proline-4-hydroxylase gene”) which is useful for the above-mentionedprocess, a transformant containing the gene, and a process for producingL-proline-4-hydroxylase using the transformant.

In addition, this invention relates to a process for industriallyproducing trans-4-hydroxy-L-proline using a transformant which containsL-proline-4-hydroxylase gene and has a reinforced proline biosynthesisactivity.

BACKGROUND OF THE INVENTION

The following processes are known as a method for producingtrans-4-hydroxy-L-proline using microorganisms.

1) A process in which trans-4-hydroxy-L-proline is produced from4-hydroxy-2-oxoglutaric acid using microorganisms of the genusEscherichia (Japanese Published Unexamined Patent Application No.266,995/91)

2) A process in which trans-4-hydroxy-L-proline is produced directlythrough fermentation using bacteria or fungi (European (EP 0 547 898 A2,and Japanese Published Unexamined Patent Application Nos. 236,980/93 and245,782/94)

3) A process in which trans-4-hydroxy-L-proline is produced fromL-proline using microorganisms of the genus Streptomyces [J. Biol.Chem., 254, 6684 (1979), Biochem. Biophys. Res. Comm., 120, 45, (1984),Tetrahedron Letters, 34, 7489 (1993), and Tetrahedron Letters, 35, 4649(1994)].

The conventional processes can, however, hardly be performed on anindustrial scale for the following reasons:

1) A substrate for producing trans-4-hydroxy-L-proline, such as4-hydroxy-2-oxoglutaric acid is too expensive and is difficult toobtain.

2) The productivity of trans-4-hydroxy-L-proline is low.

3) The activity of the enzymes that relate to the production oftrans-4-hydroxy-L-proline is quite weak.

Heretofore, L-proline-4-hydroxylase has not been isolated. A process forproducing trans-4-hydroxy-L-proline, using an enzyme source which isisolated from a microorganism belonging to the genus Dactylosporangiumor Amycolatopsis and which catalyzes the hydroxylation of L-proline intotrans-4-hydroxy-L-proline, has not been known. Although there was apaper reporting that L-proline-4-hydroxylase was isolated from amicroorganism belonging to the genus Streptomyces (Tetrahedron Letters,34, 7489-7492, 1993), the report is silent about steps for isolating theenzyme, the enzyme purity, the physicochemical properties of the enzyme,etc.

With respect to the enzyme that catalyzes the production oftrans-4-hydroxy-L-proline, it was reported in a paper thatL-proline-4-hydroxylase is purified from a microorganism of the genusStreptomyces. However, a method for obtaining the enzyme andphysicochemical properties of the enzyme are not described therein.Further, no paper reported that a gene encoding L-proline-4-hydroxylasehaving the activity of converting free L-proline intotrans-4-hydroxy-L-proline in the presence of 2-ketoglutaric acid and adivalent iron ion had been cloned.

A process in which trans-4-hydroxy-L-proline is produced industriallyadvantageously using L-proline-4-hydroxylase having a high level ofactivity has been in demand.

The object of the present invention is to provide an efficient processfor the production of trans-4-hydroxy-L-proline on the industriallyapplicable basis, and the additional object of the present invention isto provide a novel enzyme which catalyzes the hydroxylation of L-prolineat the 4-position of L-proline and which is useful in the above process.

SUMMARY OF THE INVENTION

The present invention provides a process for the production oftrans-4-hydroxy-L-proline which comprises allowing L-proline to coexistwith 2-ketoglutaric acid, a divalent iron ion and an enzyme source whichcatalyzes hydroxylation of L-proline at the 4-position of L-proline inan aqueous medium to convert L-proline into trans-4-hydroxy-L-proline,and recovering the trans-4-hydroxy-L-proline from the aqueous medium.

The present invention further provides a novel hydroxylase(L-proline-4-hydroxylase)having the following physicochemicalproperties:

(1) Action and Substrate Specificity

The enzyme catalyzes hydroxylation of L-proline at the 4-position ofL-proline in the presence of 2-ketoglutaric acid and a divalent iron ionto produce trans-4-hydroxy-L-proline.

(2) Optimum pH Range

The enzyme has an optimum pH range of 6.0 to 7.0 for its reaction at 30°C. for 20 minutes.

(3) Stable pH Range

The enzyme is stable at pH values of 6.5 to 10.0, when it is allowed tostand at 4° C. for 24 hours.

(4) Optimum Temperature Range

The optimum temperature range is 30 to 40° C. when it is allowed tostand at pH 6.5 for 15 minutes.

(5) Stable Temperature Range

The enzyme is inactivated, when it is allowed to stand at pH 9.0 and at50° C. for 30 minutes.

(6) Inhibitors

The activity of the enzyme is inhibited by metal ions of Zn⁺⁺ and Cu⁺⁺and ethylenediaminetetraacetic acid.

(7) Activation

The enzyme does not need any cofactors for its activation.

L-Ascorbic acid accelerates the activity of the enzyme.

(8) Km Value

Km value is 0.27 mM for L-proline and is 0.55 mM for 2-ketoglutaricacid, when determined in a 80 mM 2-(N-morpholino)ethanesulfonic acid(MES) buffer (pH 6.5) containing 4 mM L-ascorbic acid, 2 mM ferroussulfate and the enzyme preparation.

(9) Molecular Weight

The enzyme has a molecular weight of 32,000±5,000 daltons by sodiumdodecylsulfate-polyacrylamide gel electrophoresis and of 43,800±5,000daltons by gel filtration.

(10) N-Terminal Amino Acid Sequence

The enzyme has an N-terminal amino acid sequence illustrated by SequenceNo. 1 mentioned below.

Sequence No. 1: (N-terminal)  1 MetLeuThrProThrGluLeuLysGlnTyr 11ArgGluAlaGlyTyrLeuLeuIleGluAsp 21 GlyLeuGlyProArgGluVal

The present invention also provides an L-proline-4-hydroxylase gene anda transformant containing the above-mentioned gene for producingtrans-4-hydroxy-L-proline efficiently and industrially advantageouslyusing L-proline-4-hydroxylase from L-proline that is available at lowcost, a process for mass-producing the L-proline-4-hydroxylase using thegene and the transformant, and a process for producingtrans-4-hydroxy-L-proline industrially at low cost using thetransformant or the L-proline-4-hydroxylase.

In addition, the present invention provides a transformant, whichcontains the above-mentioned gene for producingtrans-4-hydroxy-L-proline and has reinforced proline biosynthesisactivity, and a process for producing trans-4-hydroxy-L-proline usingthe transformant industrially at low cost.

BRIEF DESCRIPTION OF DRAWINGS

FIG. 1 shows a restriction enzyme map of plasmid pRH71 and the steps ofconstructing plasmids pYan10 and pYan13.

In the figure, the thick, shadowed lines each indicate a clonedDactylosporangium sp. RH1 chromosome site. Ap indicates a pBR322-derivedampicillin-resistant gene. In the figure, only the restriction enzymesites having relation to the construction of the plasmids are shown.

FIG. 2 shows the steps of constructing plasmid pTr14.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. Ap indicates a pBR322-derivedampicillin-resistant gene; and Ptrp indicates a promoter of Escherichiacoli tryptophan operon. The arrows each indicate the direction in whichthe gene is transcribed and translated. In the figure, only therestriction enzyme sites having relation to the construction of theplasmid are shown.

FIG. 3 shows the steps of constructing plasmid pTc4OH.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. Ap indicates a pBR322-derivedampicillin-resistant gene; and Ptac indicates tac promoter. The arrowseach indicate the direction in which the gene is transcribed andtranslated. In the figure, only the restriction enzyme sites havingrelation to the construction of the plasmid are shown.

FIG. 4 shows the steps of constructing plasmid pTr2-4OH.

In the figure, the thick, solid black line each indicate a part thatcontains an L-proline 4-hydroxylase gene. Ap indicates a pBR322-derivedampicillin-resistant gene; and Ptrpx2 indicates a promoter composed oftwo promoters of Escherichia coli-derived tryptophan operon as connectedin series (tandem tryptophan promoter). The arrows each indicate thedirection in which the gene is transcribed and translated. In thefigure, only the restriction enzyme sites having relation to theconstruction of the plasmid are shown.

FIG. 5 shows the steps of constructing plasmid pTr2-4OHΔ.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. Ap indicates a pBR322-derivedampicillin-resistant gene; and Ptrpx2 indicates a promoter composed oftwo promoters of Escherichia coli-derived tryptophan operon as connectedin series (tandem tryptophan promoter). The arrows each indicate thedirection in which the gene is transcribed and translated. In thefigure, only the restriction enzyme sites having relation to theconstruction of the plasmid are shown.

FIG. 6 shows the steps of constructing plasmid pWFH1.

In the figure, the thick, shadowed lines each indicate a site into whicha PCR-amplified fragment as treated with HindIII and SalI is inserted.The thick, solid black lines each indicate a part that contains aDactylosporangium sp. RH1-derived L-proline 4-hydroxylase gene. Apindicates a pBR322-derived ampicillin-resistant gene; and Ptrpx2indicates a promoter composed of two promoters of Escherichiacoli-derived tryptophan operon as connected in series (tandem tryptophanpromoter). The arrows each indicate the direction in which the gene istranscribed and translated. In the figure, only the restriction enzymesites having relation to the construction of the plasmid are shown.

FIG. 7 shows the steps of constructing plasmid pES1-23a.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. lacZ indicates Escherichiacoli β-galactosidase gene; Ap indicates a pBR322-derivedampicillin-resistant gene; and Plac indicates lac promoter. The arrowseach indicate the direction in which the gene is transcribed andtranslated. In the figure, only the restriction enzyme sites havingrelation to the construction of the plasmid are shown.

FIG. 8 shows the steps of constructing plasmid pMc4OH.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. malE indicates Escherichiacoli maltose-binding protein gene; lacZ indicates Escherichia coliβ-galactosidase gene; Ap indicates a pBR322-derived ampicillin-resistantgene; lacI^(q) indicates a repressor gene of Escherichia coli lactoseoperon; rrnB terminator indicates a terminator of rrnB gene; and Ptacindicates tac promoter. The arrows each indicate the direction in whichthe gene is transcribed and translated. In the figure, only therestriction enzyme sites having relation to the construction of theplasmid are shown.

FIG. 9 shows the steps of constructing plasmid pBAB51.

In the figure, the thick, shadowed lines each indicate prolinebiosynthesis genes proB74 and proA. Ap indicates a pBR322-derivedampicillin-resistant gene; lacZ indicates β-galactosidase α fragmentconstruction gene; and Tc indicates a pBR322-derivedtetracycline-resistant gene. The arrows each indicate the direction inwhich the gene is transcribed and translated. In the figure, only therestriction enzyme sites having relation to the construction of theplasmid are shown.

FIG. 10 shows the steps of constructing plasmid pPRO74.

In the figure, the thick, shadowed lines each indicate prolinebiosynthesis genes proB74 and proA. The thick, solid black lines in thethick, shadowed lines indicate proB74 gene containing one base pairwhich is different from proB gene. Tc indicates a pBR322-derivedtetracycline-resistant gene. The arrows each indicate the direction inwhich the gene is transcribed and translated. In the figure, only therestriction enzyme sites having relation to the construction of theplasmid are shown.

FIG. 11 shows the steps of constructing plasmid pPF1.

In the figure, the thick, shadowed lines each indicate prolinebiosynthesis genes proB74 and proA. Cm^(r) indicates Tn9-derivedchloramphenicol resistant gene; pACYC.ori indicates pACYC184-derivedreplication origin; Plac indicates lac promoter; lacZ indicatesβ-galactosidase α fragment construction gene; and lacZ.Nterm-proB74indicates the gene coding for a protein which unites N-terminal aminoacids of B-galactosidase a fragment with a protein encoded by proB74.The arrows each indicate the direction in which the gene is transcribedand translated. In the figure, only the restriction enzyme sites havingrelation to the construction of the plasmid are shown.

FIG. 12 shows the steps of constructing plasmid pBII-4OH.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. Ap indicates a pBR322-derivedampicillin-resistant gene; and lacZ indicates β-galactosidase a fragmentconstruction gene. The arrows each indicate the direction in which thegene is transcribed and translated. In the figure, only the restrictionenzyme sites having relation to the construction of the plasmid areshown.

FIG. 13 shows the steps of constructing plasmid pBII-4OHBA.

In the figure, the thick, solid black lines each indicate apart thatcontainsanL-proline4-hydroxylasegene. Apindicates a pBR322-derivedampicillin-resistant gene; and lacZ indicates β-galactosidase α fragmentconstruction gene. The arrows each indicate the direction in which thegene is transcribed and translated. In the figure, only the restrictionenzyme sites having relation to the construction of the plasmid areshown.

FIG. 14 shows the steps of constructing plasmid pWFP1.

In the figure, the thick, solid black lines each indicate a part thatcontains an L-proline 4-hydroxylase gene. The thick, shadowed lines eachindicate proline biosynthesis genes proB74 and YroA. Ap indicates apBR322-derived ampicillin-resistant gene; and lacZ indicatesβ-galactosidase α fragment construction gene. Ptrpx2 indicates apromoter composed of two promoters of Escherichia coli-derivedtryptophan operon as connected in series (tandem tryptophan promoter).The arrows each indicate the direction in which the gene is transcribedand translated. In the figure, only the restriction enzyme sites havingrelation to the construction of the plasmid are shown.

DETAILED DESCRIPTION OF THE INVENTION

As the enzyme source to be used in the process for producingtrans-4-hydroxy-L-proline of the present invention, any microorganismcan be used so long as it has an enzymatic activity of catalyzing thehydroxylation of L-proline at the 4-position of L-proline in thepresence of 2-ketoglutaric acid and a divalent iron ion. As themicroorganism having such activity, mention may be made ofmicroorganisms belonging to the genus Dactylosporangium orAmycolatopsis. The preferred strain of such microorganism includesDactylosporangium sp. RH1 and Amycolatopsis sp. RH2. Specifically, aculture, cells or processed cells of these strains can be used. Further,a crude enzyme preparation from cells of the microorganism as mentionedabove, a purified product of such enzyme preparation, an immobilizedenzyme preparation, etc. can be used.

The strains RH1 and RH2 were newly isolated by the present investorsfrom a tree in Tokyo, Japan and from the soil in Saitama, Japan,respectively. The bacteriological properties of the strains RH1 and RH2are described below.

1. Morphological Properties

The morphological properties when the strains were cultivated on variousmedia at 28° C. for 14 days are shown in Table 1 below.

TABLE 1 Morphological Properties Strain RH1 Strain RH2 1) HyphaeBranching mode of Simple branching Simple branching hyphae Formation ofNot observed Yes aerial hyphae Fragmentation of Yes aerial hyphaeFragmentation of Not observed Yes substrate hyphae 2) Spores SporulationObserved Not observed Positions to which (as sporangiospores) sporesadhere Adhered to Morphology of substrate hyphae sporangia Rods,existing Not observed singly or as bundles composed of several rodsporangia. Number of 2 to 4 sporangiospores per one sporangiumCharacteristics of sporangiospores Surface Smooth Shape Oval sphere Size0.6 to 0.8 μm × 1.0 to 2.0 μm Motility Yes 3) Others Globose bodiesObserved Not observed Pseudosporangia Not observed Not observedChlamydospores Not observed Not observed Synnema Not observed Notobserved

2. Cultural Characteristics in Various Media

The strain RH1 grows normally or vigorously on usual synthetic andnatural media, while its substrate hyphae are orange. On some media, thestrain often produces ocher or pale red soluble pigments.

The strain RH2 grows normally or vigorously on usual synthetic andnatural media, while its substrate hyphae are pale yellow or brown andits aerial hyphae are white or gray. On some media, the strain oftenproduces brown soluble pigments.

The cultural characteristics in the growth conditions and the colors ofthe strain RH1 and the strain RH2, when the strains were cultivated onvarious media at 28° C. for 14 days, are shown in Table 2. Thedesignation of the colors has been made, according to the classificationof colors indicated in Color Harmony Manual published by ContainerCorporation of America.

TABLE 2 Cultural Characteristics in Various Media Strain RH1 StrainRH2 1) Sucrose-nitrate agar Growth Moderate Poor Color of substrateApricot Pearly pink hyphae (4ga) (3ca) Formation of aerial None Poorhyphae Color of aerial White (a) hyphae Soluble pigments None None 2)Glucose-asparagine agar Growth Moderate Moderate Color of substrateLight gray to Light tan hyphae luggage tan (3gc) (c to 4ne) Formation ofaerial None Poor hyphae Color of aerial White to light hyphae amber (ato 3ic) Soluble pigments None Produced only a little (ocher) 3) Glycerolasparagine agar Growth Poor Moderate Color of substrate Light melonLight white to hyphae yellow (3ea) cinnamon (2ea to 31e) Formation ofaerial None Moderate hyphae Color of aerial White (a) hyphae Solublepigments None Produced only a little (ocher) 4) Inorganic salt starchagar Growth Moderate Moderate Color of substrate Camel (3ie) Lightmustard hyphae tan to cinnamon (2ic to 31e) Formation of aerial NoneModerate hyphae Color of aerial White to light hyphae gray (a to d)Soluble pigments None Produced only a little (ocher) 5) Tyrosine agarGrowth Moderate Moderate Color of substrate Apricot Mustard gold tohyphae (4ia) golden brown (2pg to 3pg) Formation of aerial None Nonehyphae Color of aerial White (a) hyphae Soluble pigments Produced onlyProduced a little (brown) (pale red) 6) Nutrient agar Growth Poor PoorColor of substrate Bright melon Yellow maple hyphae yellow (3ia) (3ng)Formation of aerial None Moderate hyphae Color of aerial Light gray (b)hyphae Soluble pigment Produced only a Produced (brown) little (ocher)7) Yeast extract-malt extract agar Growth Abundant Good Color ofsubstrate Orange (41A) Mustard gold to hyphae golden brown (2pg) to(3pg) Formation of aerial Not formed Moderate hyphae Color of aerialPearl (2ba) hyphae Soluble pigments Produced only a Produced (brown)little (ocher) 8) Oatmeal agar Growth Poor or moderate Poor Color ofsubstrate Apricot Mustard gold hyphae (4ia) (2pg) Formation of aerialNone Poor hyphae Color of aerial Natural hyphae (3dc) Soluble pigmentsProduced only a Produced only a little (ocher) little (ocher)

3. Physiological Properties

The physiological properties of the strains RH1 and RH2 are shown inTable 3, in which the “temperature range for growth” indicates theresults of each strain after 7 day-cultivation with shaking. Theremaining items indicate the results after 2 to 3 week-cultivation at28° C.

TABLE 3 Physiological Properties Strain RH1 Strain 1) Temperature Rangefor Growth 20 to 37° C. 13 to 35° C. 2) Liquefaction of Gelatin − + 3)Hydrolysis of Starch + + 4) Coagulation of Skim Milk − + Powder 5)Peptonization of Skim Milk − + Powder 6) Formation of Melancid Pigment(1) Peptone-yeast extract − + iron agar (2) Tyrosine agar + + 7)Utilization of Carbon Sources (*) L-Arabinose + − D-Glucose + +D-Xylose + + Sucrose + (+) Raffinose (+) + D-Fructose + + Rhamnose + +Inositol (+) + D-Mannitol + + (*) As the basic medium, used was PridhamGottlieb-agar medium. + indicates that the strain utilized the carbonsource; − indicates that the strain did not utilize the carbon source;and (+) indicates that it is not clear as to whether or not the strainutilized the carbon source.

4. Chemotaxonomic Properties

The chemotaxonomic properties of the strains RH1 and RH2 are shown inTable 4.

TABLE 4 Chemotaxonomic Properties Strain RH1 Strain RH2 1) Configurationof 3-OH (meso) Mesa form diaminopimelic form acid in cell wall 2)Reducing sugars in Galactose and minor hydrolysate of amount ofarabinose cell wall 3) Reducing sugars in Arabinose and Arabinose andgalactose hydrolysate of xylose whole cell 4) Mycolic acid Not contained5) Phospholipid The cells contain phosphatidyl- ethanolamine but do notcontain phosphatidyl- choline and unknown glucosamine-containingphospholipids. 6) Menaquinone The cells contain MK-9 (H₄) as the majorcomponent.

Accordingly, the strain RH1 is classified to the genus Dactylosporanqiumof actinomycetes in view of its properties (1) that it does not formaerial hyphae, (2) that it forms rod-like sporangia on its substratehyphae, (3) that its sporangia contain from 2 to 4 motile spores each,(4) that the diaminopimelic acid contained in its cell wall is3-hydroxydiaminopimelic acid and (5) that the hydrolysate of its wholecell contains reducing sugars of arabinose and xylose.

The strain RH2 is identified as the genus Amycolatopsis of actinomycetesin view of its properties (1) that it forms aerial hyphae, (2) that itsaerial hyphae and substrate hyphae fragmented into coccoidor rod-shapedelements, (3) that its cell wall contains meso-diaminopimelic acid andreducing sugars of galactose and a slight amount of arabinose, (4) thatthe hydrolysate of its whole cell contains reducing sugars of arabinoseand galactose, (5) that it does not contain mycolic acid as itscell-constitutive component (6) that it contains a phospholipid ofphosphatidylethanolamine but does not contain phosphatidylcholine andunknown glucosamine-containing phospholipids and (7) that the majorcomponent of its major menaquinone is MK-9 (H₄).

The strain RH1 was named Dactylosporangium sp. RH1 and the strain RH2was named Amycolatopsis sp. RH2. These strains have been deposited withNational Institute of Bioscience and Human-Technology, Agency ofIndustrial Science and Technology in Japan as of Sep. 1, 1993 under FERMBP-4400 for the strain RH1 and as of Feb. 22, 1994 under FERM BP-4581for the strain RH2, both in terms of the Budapest Treaty.

The medium for cultivating these microorganisms may be any of naturalmedia and synthetic media, so long as it contains carbon sources,nitrogen sources, inorganic salts, etc. that may be assimilated bymicroorganisms having an activity of catalyzing hydroxylation ofL-proline to produce trans-4-hydroxy-L-proline.

As the carbon sources, carbohydrates such as glucose, fructose, sucrose,molasses containing these components, starch and starch hydrolysates;organic acids such as acetic acid, propionic acid; alcohols such asethanol and propanol may be used.

As the nitrogen sources, ammonia; ammonium salts of various inorganicacids and organic acids such as ammonium chloride, ammonium sulfate,ammonium acetate and ammonium phosphate; other nitrogen-containingcompounds; peptone, meat extracts, yeast extracts, corn steep liquor,casein hydrolysates, soy bean cakes, soy bean cake hydrolysates, variouscultured cells of microorganisms, their digested products, etc. may beused.

The inorganic material includes, for example, potassium dihydrogenphosphate, dipatassium hydrogen phosphate, magnesium phosphate,magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate,copper sulfate, calcium carbonate, etc.

The cultivation of these microorganisms is carried out under aerobicconditions, for example, with shaking culture or submerged-aerialstirring culture. The temperature for the cultivation is preferably from15 to 37° C., and the period for the cultivation is generally from 16 to96 hours. During the cultivation, the pH of the medium is kept at 5.0 to9.0 with inorganic or organic acids, alkaline solutions, urea, calciumcarbonate, ammonia, etc.

The thus-cultivated microorganisms can be used as the enzyme source tobe used in the process for producing trans-4-hydroxy-L-proline.

The amount of the enzyme source to be used in the process for producingtrans-4-hydroxy-L-proline depends on the amount of the substrate to beused in the process. Usually, it may be from 1.0 to 10,000,000 U/liter,preferably from 1,000 to 3,000,000 U/liter of the aqueous medium.

The enzyme activity for producing one nmol of trans-4-hydroxy-L-prolinefor one minute under the conditions mentioned below is defined as oneunit (U).

The enzyme preparation to be determined is added to 80 mM MES buffer (pH6.5) containing 4 mM L-proline, 8 mM 2-ketoglutaric acid, 2 mM ferroussulfate and 4 mM L-ascorbic acid to make 250 μl in total, and themixture was allowed to stand at 30° C. for 20 minutes. The reactionmixture is heated at 100° C. for 2 minutes so as to stop the reaction,and the amount of the trans-4-hydroxy-L-proline produced in the reactionmixture is determined by high performance liquid chromatography(hereinafter referred to as HPLC).

For the determination, any method capable of determining the amount oftrans-4-hydroxy-L-proline maybe employed. For instance, generally usableare a post-column derivatization method where HPLC is utilized, and apre-column derivatization method where the compound to be determined inthe reaction mixture is previously reacted with7-chloro-4-nitrobenz-2-oxa-1,3-diazole (hereinafter referred to as NBD)to form its NBD-derivative, the derivative is separated byreversed-phase chromatography using HPLC and the thus-separatedderivative is quantitatively determined by spectrofluorometry(excitation wavelength: 503 nm, emission wavelength: 541 nm). Thepre-column derivatization method may be conducted, according to themethod of William J. Lindblad & Robert F. Diegelmann, et al. [seeAnalytical Biochemistry, 138, 390 (1984)].

The concentration of L-proline to be used in the process for producingtrans-4-hydroxy-L-proline may be from 1 mM to 2 M.

The process for producing trans-4-hydroxy-L-proline needs a divalentiron ion. The concentration of the divalent iron ion may be generallyfrom 1 to 100 mM. Any divalent iron ion may be used so long as it doesnot inhibit the enzymatic reaction. For instance, sulfides such asferrous sulfate, chlorides such as ferrous chloride and ferrouscarbonate, the salts of organic acids such as citrates, lactates andfumarates may be used.

The process also needs 2-ketoglutaric acid. The concentration of2-ketoglutaric acid is generally from 1 mM to 2M. 2-Ketoglutaric aciditself may be added to the aqueous medium, or alternatively, thecompound that may be converted into 2-ketoglutaric acid by the metabolicactivity of the microorganism used in the enzymatic reaction may beadded thereto. The compound includes, for example, saccharides such asglucose, glutamic acid and succinic acid. These compounds may be usedsingly or in combination.

The aqueous medium to be used in the process for producingtrans-4-hydroxy-L-proline of the present invention includes, forexample, water, buffers such as phosphates, carbonates, acetates,borates, citrates and tris-buffers, alcohols such as methanol andethanol, esters such as ethyl acetate, ketones such as acetone, andamides such as acetamide.

The enzymatic reaction may be carried out in the aqueous medium wherethe above-mentioned microorganisms having an activity of catalyzinghydroxylation of L-proline to produce trans-4-hydroxy-L-proline arebeing cultivated or have been cultivated, or alternatively, theenzymatic reaction may also be carried out in an aqueous mediumcontaining the cells of the above mentioned microorganisms separatedfrom the culture, a processed cells, or a purified or crude enzymederived from the cells.

Processed cells of the microorganisms include, for example, dried cells,lyophilized cells, surfactant-treated cells, enzymatically-treatedcells, ultrasonically-treated cells, mechanically-ground cells,mechanically-compressed cells, solvent-treated cells, fractionated cellproteins, immobilized cells, immobilized materials obtained byprocessing their cells, etc.

The enzymatic reaction is generally carried out at a temperature of 15to 50° C. and at pH 6.0 to 9.0, for a period of 1 to 96 hours. Ifdesired, surfactants and/or organic solvents may be added during theprocessing of the cells or during the enzymatic reaction.

As the surfactants, mention may be made of cationic surfactants such aspolyoxyethylene-stearylamine (e.g., Nymeen S-215, produced by NipponOils and Fats Co.), cetyltrimethylammonium bromide, Cation FB and CationF2-40E, etc.; anionic surfactants such as sodium oleylamidosulfate,Newrex TAB and Rapizole 80; ampholytic surfactants such aspolyoxyethylene-sorbitanmonostearate (e.g., NonionST221; other tertiaryamines PB, hexadecyldimethylamine, etc. Any surfactant that may promotethe reaction may be employed. The concentration of the surfactant to beemployed in the reaction may be generally from 0.1 to 50 mg/ml,preferably from 1 to 20 mg/ml.

As the organic solvent, mention may be made of toluene, xylene,aliphatic alcohols, benzene, ethyl acetates etc. Generally, theconcentration of the solvent in the process may be from 0.1 to 50 μl/ml,preferably from 1 to 20 μl/ml.

To recover trans-4-hydroxy-L-proline from the aqueous medium, ordinaryseparation methods such as column chromatography using an ion-exchangeresin, crystallization, etc. may be employed.

The structure of the recovered trans-4-hydroxy-L-proline can beidentified by ordinary analytical method such as ¹³C-NMR spectrum,¹H-NMR spectrum, mass spectrum, specific rotation or the like.

Next, the novel enzyme, the L-proline-4-hydroxylase of the presentinvention is described below.

The L-proline-4-hydroxylase may be obtained by cultivatingmicroorganisms having an ability to produce L-proline-4-hydroxylase in amedium so as to produce and accumulate the L-proline-4-hydroxylase inthe culture medium, and recovering the L-proline-4-hydroxylase from thecells.

Any microorganisms having an ability to produce L-proline-4-hydroxylasemay be employed. For example, microorganisms belonging to the genusDactylosporangium or Amycolatopsis and having such activity can be used.Specific examples are the above-mentioned Dactylosporangium sp. RH1,Amycolatopsis sp. RH2, a subcultivated strain thereof, its mutantthereof, its derivative thereof, etc.

The medium for cultivating these microorganisms may be any of naturalmedia and synthetic media, so long as it contains carbon sources,nitrogen sources, inorganic salts, etc. that may be assimilated bymicroorganisms having an ability to produce L-proline-4-hydroxylase.

The carbon source includes, for example, carbohydrates such as glucose,fructose, sucrose, molasses containing these components, starch andstarch hydrolysates; organic acids such as acetic acid and propionicacid; alcohols such as ethanol and propanol which may be assimilated bythe microorganisms.

As the nitrogen source, ammonia; ammonium salts of various inorganicacids and organic acids such as ammonium chloride, ammonium sulfate,ammonium acetate and ammonium phosphate; other nitrogen-containingcompounds; peptone, meat extracts, yeast extracts, corn steep liquor,casein hydrolysates, soy bean cakes, soy bean cake hydrolysates, variousmicroorganisms for fermentation, their digested products, etc. may beused.

As the inorganic material, dipotassium hydrogen phosphate, potassiumdihydrogen phosphate, magnesium phosphate, magnesium sulfate, sodiumchloride, ferrous sulfate, manganese sulfate, copper sulfate, calciumcarbonate, etc. can be used.

The cultivation of these microorganisms is carried out under aerobicconditions, for example, with shaking culture or submerged-aerialstirring culture. The temperature for the cultivation is preferably from15 to 37° C., and the period for the cultivation is generally from 16 to96 hours.

During the cultivation, the pH of the medium is kept at 5.0 to 9.0 withinorganic or organic acids, alkaline solutions, urea, calcium carbonate,ammonia, etc. During the cultivation, L-proline may be added, ifdesired.

To isolate and purify the enzyme from the culture containing the enzyme,any ordinary method for isolating and purifying an enzyme may beemployed. For instance, the culture is subjected to centrifugation tocollect the cultivated cells therefrom, and the cells are fully washedand then disrupted by an ultrasonic cell disrupter, a French press, aManton-Gauline homogenizer, a Dyno mill, etc. to obtain a cell-freeextract. The cell-free extract is again subjected to centrifugation, andthe enzyme in the resulting supernatant is then purified, for example,by salting-out with ammonium sulfate or the like, by anion-exchangechromatography with diethylaminoethyl (DEAE)-Sepharose or the like, byhydrophobic chromatography with butyl-Sepharose, phenyl-Sepharose or thelike, by dye affinity chromatography with red-Agarose or the like, bygel filtration with molecular sieves or by electrophoresis such asisoelectric point electrophoresis or the like. In this way, a pureproduct of the enzyme is obtained. The activity of theL-proline-4-hydroxylase thus isolated may be determined by the samemethod as mentioned above.

The L-proline-4-hydroxylase, thus obtained according to the mannermentioned above, has the following physicochemical properties (1) to(10);

(1) Action and Substrate Specificity

The hydroxylase catalyzes hydroxylation of L-proline at the 4-positionof L-proline in the presence of 2-ketoglutaric acid and a divalent ironion to form trans-4-hydroxy-L-proline.

(2) Optimum pH Range

In the above-mentioned method of determining the activity of thehydroxylase, the reaction was carried out while the buffer component inthe reaction mixture was changed to sodium acetate buffer at pH of 3.5to 5.5, it was changed to MES buffer at pH of 5.5 to 6.5, it was changedto TES buffer [N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid]at pH of 7.0 to 7.5, it was changed to TAPS buffer[N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid] at pH of, 8.0to 9.0, and it was changed to CAPSO buffer(3-N-cyclohexylamino-2-hydroxypropanesulfonic acid) at pH of 9.5 to11.0. As a result, it was found that the optimum pH range for the enzymewas in the range of pH 6.0 to pH 7.0.

(3) Stable pH Range

The enzyme was allowed to stand in the presence of 50 mM of a buffer(sodium acetate buffer at pH of 3.5 to 5.5, MES buffer at pH of 5.5 to6.5, TES buffer at pH of 7.0 to 7.5, TAPS buffer at pH of 8.0 to 9.0,CAPSO buffer at pH of 9.5 to 11.0), 2 mM dithiothreitol (DTT) and 20%(v/v) of glycerol, at 4° C. for 24 hours, and then its activity wasdetermined. The enzyme kept at pH ranging from 6.5 to 10.0 had anactivity of 90% or more of the original activity of the enzyme.Accordingly, it was found that the enzyme was stable at pH ranging from6.5 to 10.0.

(4) Optimum Temperature Range

In the above-mentioned method of determining the activity of thehydroxylase acting on the 4-position of L-proline, the activity of theenzyme was determined, varying the temperature. As a result, it wasfound that the enzyme had an optimum temperature ranging from 30 to 40°C. in the reaction at pH of 6.5 for 15 minutes.

(5) Stable Temperature Range

When the enzyme was allowed to stand at 50° C. and at pH of 9.0 for 30minutes, it was inactivated.

(6) Inhibitors

The activity of the enzyme is inhibited by metal ions of Zn⁺⁺ and Cu⁺⁺and by EDTA. According to the above mentioned method of determining theactivity of the hydroxylase acting on the 4-position of L-proline, whenthe activity of the enzyme was determined in the presence of Cu⁺⁺ andZn⁺⁺ ions of 1 mM each, it was lowered, to 13% and 6%, respectively, ofthe original activity of the enzyme. Likewise, when the activity of theenzyme was determined in the presence of 5 mM EDTA, no activity of theenzyme was detected.

(7) Activation

No activation of the enzyme was observed, when various metal ions andcofactors were added thereto. Accordingly, the activation of the enzymedoes not need any cofactor.

Ascorbic acid promotes the activity of the enzyme.

(8) Km Value

The Km values of the enzyme were 0.27 mM for L-proline and 0.55 mM for2-ketoglutaric acid, when determined in the reaction system containing80 mM MES buffer (pH 6.5), 4 mM L-ascorbic acid, 2 mM ferrous sulfateand a pre-determined amount of the enzyme.

(9) Molecular Weight

The molecular weight of the enzyme was calculated to be 32,000±5,000daltons, by sodium dodecylsulfate polyacrylamide gel electrophoresis[using polyacrylamide gel, PAGEL NPU-12.5L (produced by Atto Co.) andMolecular Weight Standard Broad Range SDS-PAGE (produced by BioradCo.)]. It was calculated to be 43, 800±5,000 daltons, by gel filtrationwith HPLC (using a column of G-3000SW having a size of 21.5 mm×60 cm;and a molecular weight marker for HPLC produced by Oriental Yeast Co. asthe standard)

(10) N-terminal Amino Acid Sequence

The enzyme has an N-terminal amino acid sequence illustrate by SequenceNo. 1.

Sequence No. 1: (N-terminal)  1 MetLeuThrProThrGluLeuLysGlnTyr 11ArgGluAlaGlyTyrLeuLeuIleGluAsp 21 GlyLeuGlyProArgGluVal

The L-proline-4-hydroxylases of the present invention are enzymes bywhich free L-proline is hydroxylated in the presence of 2-ketoglutaricacid and a divalent ion to form trans-4-hydroxy-L-proline.

The present invention encompasses any and every protein having theenzymatic activity of hydroxylating the 4-position of L-proline, whichincludes, for example, a protein having the amino acid sequenceindicated by Sequence No. 2, a fused protein having an amino acidsequence that results from the protein or a protein having a partialamino acid sequence of the protein as bonded to a peptide having apartial amino acid sequence of an Escherichia coli-derivedβ-galactosidase protein, a fused protein having an amino acid sequencethat results from the protein having the amino acid sequence indicatedby Sequence No. 2 or a protein having a partial amino acid sequence ofthe protein as bonded to a peptide having a partial amino acid sequenceof an E. coli-derived maltose-binding protein, etc. Examples of thefused proteins include a proteins having the amino acid sequence asindicated by Sequence No. 19 or 20, etc.

The protein having the amino acid sequence indicated by Sequence No. 2,19 or 20 includes proteins having an amino acid sequence with one ormore amino acids substituted, deleted or added and having the enzymaticactivity of hydroxylating the 4-position of L-proline. The substitution,the deletion and the addition of amino acids can be conducted inaccordance with the methods described in Nucleic Acids Research, 10,6487 (1982); Proc. Natl. Acad. Sci. USA., 79, 6409 (1982); Proc. Natl.Acad. Sci. USA., 81, 5662 (1984); Science, 224, 1431 (1984); PCTWO85/00817 (1985); Nature, 316, 601(1985); Gene, 34, 315 (1985); NucleicAcids Research, 13, 4431 (1985); Current Protocols in Molecular Biology,Chap. 8, Mutagenesis of Cloned DNA, John Wiley & Sons, Inc. (1989), etc.

The present invention encompasses any and every L-proline-4-hydroxylasegene of a DNA fragment containing a gene that codes for a protein havingthe enzymatic activity of hydroxylating the 4-position of L-proline, andthis may include, for example, genes coding for the protein having theamino acid sequence as indicated by Sequence No. 2, 19 or 20, and alsogenes which code for a protein that has an amino acid sequencecorresponding to the amino acid sequence as indicated by Sequence No. 2,19 or 20 and derived therefrom by substitution, deletion or addition ofat least one amino acid and which have the enzymatic activity ofhydroxylating the 4-position of L-proline. Concretely mentioned are DNAsindicated by Sequence Nos. 3, 9 and 16, etc.

The L-proline-4-hydroxylase genes of the present invention include theDNAs as defined hereinabove and also DNAs as derived therefrom bymutation, such as substituting mutation, deleting mutation, insertingmutation or the like, to be conducted to the extent that the mutatedDNAs do not lose the L-proline-4-hydroxylase activity, for example, DNAswith homology to Sequence No. 3, 9 or 16. Such homologous DNAs are thoseto be obtained by colony hybridization or plaque hybridization using, asa probe, the DNA having the nucleotide sequence as indicated by SequenceNo. 3, 9 or 16. These treatments can be conducted in accordance withknown in vitro recombination techniques [see Molecular Cloning: ALaboratory Manual, 2nd Ed., edited by Sambrook, Fritsch, Maniatis,published by Cold Spring Harbor Laboratory Press, 1989].

The DNA fragment containing the L-proline-4-hydroxylase gene can beobtained from microorganisms having the ability of hydroxylatingL-proline to produce trans-4-hydroxy-L-proline. As the microorganism,any microorganism having the ability of hydroxylating L-proline toproduce trans-4-hydroxy-L-proline can be employed in the presentinvention. As preferable examples of such a microorganism,microorganisms belonging to the genus Dactylosporangium, Amycolatpsis orStreptomyces and having the activity of L-proline-4-hydroxylase can bementioned. More preferable examples thereof include Dactylosporangiumsp. RHI (FERMBP-4400), Amycolatpsis sp. RH2 (FERMBP-4581), Streptomycesgriseovirides JCM4250, Streptomyces daghestanicus JCM4365, and mutantsor derivatives of these strains.

Dactylosporangium sp. RH1 and Amycolatpsis sp. RH2 are microorganismsisolated by the present inventors isolated as those having the abilityof producing L-proline-4-hydroxylase, and Streptomyces griseoviridesJCM4250 and Streptomyces daghestanicus JCM44365 are microorganisms whoseability of producing L-proline-4-hydroxylases was found by the presentinventors for the first time.

Methods for obtaining L-proline-4-hydroxylase gene of the microorganismhaving the ability of producing L-proline-4-hydroxylase is describedbelow.

Chromosomal DNA is prepared from a microorganism having the ability ofproducing L-proline-4-hydroxylase through a usual DNA isolation method,for example, a phenol method (Biochem. Biophys. Acta, 72, 619). Thethus-obtained chromosomal DNA is cleaved with a suitable restrictionendonuclease, then the restriction endonuclease cleaved fragments areinserted into vector DNAs to construct chromosomal DNA libraries for thechromosomes of the microorganisms. Using this chromosomal DNA library, ahost microorganism can be transformed. The transformants containing theL-proline-4-hydroxylase gene are selected from the obtainedtransformants by a hybridization method. DNAs containing the intendedgene can be obtained from the thus-selected transformants.

The process comprising a series of such steps can be conducted inaccordance with known in vitro recombination method (molecular Cloning,A Laboratory Manual, 2nd edition, edited by Sambrook, Fritsch andManiatis, Cold Spring Harbor Laboratory Press, 1989).

As the vector DNAs that are used to construct the chromosomal DNAlibrary of the microorganism having the ability of producingL-proline-4-hydroxylase, phage vectors and plasmid vectors can be usedif these can be replicated autonomously in Escherichia coli K12 strain.Preferable examples of the vector DNA include λZAPII, pUC18 andpbluescript (commercially available from STRATAGENE Co.).

As the host microorganisms that are used to construct the chromosomalDNA library of the microorganism having the ability of producingL-proline-4-hydroxylase, any of the microorganisms belonging to thegenus Escherichia can be used. Preferable examples of the hostmicroorganisms include E. coli XL1-Blue, E. coli XL2-Blue, E. coli DH1,E. coli MC1000, etc.

Based on the information about the amino acid sequence ofL-proline-4-hydroxylase, DNA primers are synthesized. Using the DNAprimers, DNA fragments are prepared through polymerase chain reaction(hereinafter referred to as PCR). Using the thus-obtained DNA fragments,transformants containing an L-proline-4-hydroxylase gene can be selectedby the hybridization method.

The information on the amino acid sequences of L-proline-4-hydroxylasescan be obtained through analysis of pure L-proline-4-hydroxylases usingordinary amino acid sequencers, such as Protein Sequencer Model PPSQ-10(produced by Shimadzu Seisakusho K.K.). As the information on the aminoacid sequences thus obtained, concretely mentioned are partial aminoacid sequences in the amino acid sequence as indicated by Sequence No.2, for example, a partial amino acid sequence having the amino acidsequence from the N-terminal to the 27th amino acid sequence indicatedby Sequence No. 1, etc.

The DNA primer can be synthesized by means of an ordinary DNAsynthesizer, for example, 380A•DNA Synthesizer manufactured by AppliedBiosystems.

As the probes for the hybridization, usable are partial fragments ofL-proline-4-hydroxylase genes, which can be obtained through PCR. Forexample, a DNA as indicated by Sequence No. 4 (this corresponds to asense chain DNA coding for the first to the sixth amino acids in theamino acid sequence of Sequence No. 2) and a DNA as indicated bySequence No. 5 (this corresponds to an anti-sense chain DNA coding forthe 19th to 24th amino acids in the amino acid sequence of Sequence No.2) are chemically synthesized. Through PCR using these as DNA primers,obtained is a DNA fragment of 71 bp as indicated by Sequence No. 6. Thethus-obtained DNA fragment can be used as the probe for thehybridization.

The DNA which contains the L-proline-4-hydroxylase gene and which isobtained from the transformant selected by the hybridization, is cleavedby a suitable restriction endonucleases, for example, Xho I, and thencloned into a plasmid such as pBluescript KS(+) (commercially availablefrom STRATAGENE Co.). The nucleotide sequence of the above-mentionedgene can be determined by ordinary nucleotide-sequence determinationmethods, for example, the dideoxy chain termination method of Sanger etal. [Proc. Natl. Acad. Sci., U.S.A., 74, 5463, (1977)]. Thedetermination of the nucleotide sequence can be conducted by anautomatic DNA sequencer, for example, 373A•DNA Sequencer of AppliedBiosystems. As the thus-determined nucleotide sequences of theL-proline-4-hydroxylase genes, for example, the nucleotide sequenceindicated by Sequence No. 3 can be mentioned.

The DNA that codes for an L-proline-4-hydroxylase of the presentinvention can be introduce into vectors in a usual manner.

As the plasmids containing the DNA encoding the L-proline-4-hydroxylaseof the present invention, for example, pRH71, etc. can be mentioned.Escherichia coli SOLR/pRH71 which is Escherichia coli containing pRH71was deposited at the National Institute of Bioscience andHuman-Technology of the Agency of Industrial Science and Technology asof Mar. 2, 1995 under FERM BP-5025 in terms of the Budapest Treaty.

To express the thus-obtained L-proline-4-hydroxylase gene in the host,the DNA fragment containing the L-proline-4-hydroxylase gene is firstcleaved by a restriction endonuclease or other deoxyribonuclease to forma DNA fragment of a suitable length containing theL-proline-4-hydroxylase gene. The thus-formed DNA fragment is insertedinto an expression vector at the downstream position of the promotertherein, and thereafter the expression vector having the thus-insertedDNA therein is introduced into a host cell suitable for the expressionvector.

Any host cell that can express the intended gene can be used. Asexamples of the host cell, microbial cells of a microorganism belongingto the genus Escherichia, Serratia, Corynebacterium, Brevibacterium,Pseudomonas, and Bacillus, etc., as well as yeast strains, animal cellhosts, etc. can be mentioned.

An expression vector, which can be autonomously replicable in theabove-mentioned host cell or capable of being inserted into a chromosomeand which contains a promoter at the position where theL-proline-4-hydroxylase gene can be transcribed, can be used.

When the microorganisms such as Escherichia coli or the like are used asthe host cell, it is advisable that the expression vector is replicatedautonomously in the microorganisms and is composed of a promoter, aribosome binding sequence such as a Shine-Dargarnosequence, anL-proline-4-hydroxylase gene and a transcription termination sequence. Aregulatory gene may be contained therein.

As examples of the expression vector, mentioned are pBTrp2, pBTac1,pBTac2 (all commercially available from Behringer Manheim Co.); pKYP10(see Japanese Published Unexamined Patent Application No. 110600/83);pKYP200 [see Agric. Biol. Chem., 48, 669 (1984)]; pLSA1 [see Agric.Biol. Chem., 53, 277 (1989)]; pGEL1 [see Proc. Natl. Acad. Sci. USA.,82, 4306 (1985)]; pBluescript (produced by STRATAGENE Co.); pTrs30[prepared from Escherichia coli JM109/pTrS30 (FERM BP-5407); pTrs32[prepared from Escherichia coli JM109/pTrs32 (FERM BP-5408)], etc.

As the promoter, usable is any one capable of being expressed in hostssuch as Escherichia coli. For example, mentioned are promoters derivedfrom Escherichia coli, phage, etc., such as trp promoter (Ptrp), lacpromoter (Plac), P_(L) promoter and P_(L) promoter. Also usable areartificially designed and modified promoters, such as Ptrpx2 to beprepared by connecting two Ptrps in series, as well as tac promoter(ptac).

As the ribosome-binding sequence, any one capable of being expressed inhosts such as Escherichia coli can be used. However, it is desirable touse plasmids having a ribosome-binding sequence and an initiation codonas spaced at suitable intervals therebetween (for example, by 6 to 18bases).

The L-proline-4-hydroxylase gene includes any and every gene that codesfor an L-proline-4-hydroxylase. However, it is desirable that the basesconstituting the DNA sequence of the gene are suitably substituted inorder that the substituted DNA sequence can be constituted of codon mostsuitable for expression in the host microorganisms to be used. Asexamples of L-proline-4-hydroxylase genes where the constitutive baseshave been substituted to modify them into codons most suitable for theirexpression, mentioned are the nucleotide sequence of Sequence No. 16,etc.

Transcription terminator sequences are not always necessary for theexpression of the genes of the present invention. However, it isdesirable that a transcription terminator sequence is arranged justafter the structural gene.

Examples of the host cells usable in the present invention includeEscherichia coli XL1-Blue, Escherichia coli XL2-Blue, Escherichia coliDH1, Escherichia coli MC1000, Escherichia coli KY3276, Escherichia coliW1485, Escherichia coli JM109, Escherichia coli HB101, Escherichia coliNo. 49, Escherichia coli W3110, Escherichia coli NY49, Bacillussubtilis, Bacillus amyloliquefacines, Brevibacterium immariophilumATCC14068, Brevibacterium saccharolyticum ATCC14066, Brevibacteriumflavum ATCC14067, Brevibacterium lactofermentum ATCC13869,Corynebacterium glutamicum ATCC13032, Corynebacterium acetoacidophilumATCC13870, Microbacterium ammoniaphilum ATCC15354, etc.

When the yeast strain is used as the host cell, for example, YEp13(ATCC37115), YEp24 (ATCC37051), YCp5O (ATCC37419), etc. can be used asthe expression vector.

As the promoter, any one that can be expressed in the host cell of theyeast strain can be used. As examples of the promoters, promoters ofglycolytic genes such as hexose kinase, gal 1 promoter, gal 10 promoter,heat shock protein promoter, MFα1 promoter, and CUP 1 promoter can beused.

As examples of the host cells, Saccharomyces cerevisae,Schizosaccharomyces pombe, Kluyveromyces lactis, Trichosporon pullulans,and Schwanniomyces alluvius, etc. can be mentioned.

When the animal cells are used as the host cell, for example, pcDNAI/Amp, pcDNA I and pcDM8 (all commercially available from Funakosi Co.),etc. can be used as the expression vector.

As the promoter, any one that can be expressed in the host cell ofanimal cells can be used. For example, a promoter of an IE (immediateearly) gene of human CMV, etc. can be used. An enhancer of the IE geneof human CMV may be used together along with the promoter.

As examples of the host cells, Namalwa, HBT5637 (Japanese PublishedUnexamined Patent Application No. 299/88), COS-cell, CHO-cell, etc. canbe used.

To introduce DNA into animal cells, any and every method capable ofintroducing DNA into animal cells can be employed herein. For example,employable are electroporation methods [see Miyaji et al.,Cytotechnology, 3, 133 (1990)], calcium phosphate methods (see JapanesePublished Unexamined Patent Application No. 227075/90), lipofectionmethods [see Philip L. Felgner, et al., Proc. Natl. Acad. Sci., USA, 84,7413 (1987)], etc. The resulting transformants can be collected andcultivated in accordance with the methods described in JapanesePublished Unexamined Patent Application Nos. 227075/90 and 257891/90.

Of the hosts mentioned above, preferred are those having a reinforcedproline biosynthesis activity.

To reinforce the proline biosynthesis activity of the hosts, employableare a means of increasing the number of copies of the gene that codesfor an enzyme participating in the biosynthesis of L-proline(hereinafter referred to as “proline biosynthesis gene”) in the hosts, ameans of mutating a proline biosynthesis gene that shall be subjected tofeedback inhibition with proline to produce a mutant gene that codes foran enzyme which takes part in proline biosynthesis, to which thefeedback inhibition with proline is greatly reduced (hereinafterreferred to as “proline biosynthetase”), followed by introducing theresulting mutant gene into the hosts, a means of removing the prolinedecomposition activity from the hosts, and also a combination of any ofthese means.

The proline biosynthesis gene, or the mutant gene that codes for aproline biosynthetase can exist on the chromosomes of the hosts or canalso exist on the vectors, such as plasmids, in the hosts.

Any gene can be used so long as the gene codes for a prolinebiosynthetase. For example, it includes a gene proB74 such as thatmentioned hereinabove, a gene DHP^(r)proB, etc.

In the case of having any of the proline biosynthesis gene and themutant gene which codes for a proline biosynthetase coexist with aL-proline-4-hydroxylase gene on vectors such as plasmids in the samehost, the both genes can exist either on a single plasmid or on plural,co-existable plasmids.

For the plasmids of E. coli, for example, the combination of suchco-existable plasmids include a colicin E1 family plasmid (e.g., pBR322)and a PACYC family plasmid; a colicin E1 family plasmid and an F-factorfamily plasmid; and a colicin family E1 plasmid and an R-factor familyplasmid.

To make the host express the proline biosynthesis gene, employable isthe same process as that mentioned hereinabove for the expression ofL-proline-4-hydroxylase gene.

The host which loses proline decomposition activity can be obtained byselecting the strain which forms white colony on the Pro-TTC plate[Appl. Environ. Microbiol., 33, 434 (1977)] after processing the hostwith the mutagen.

It is known that E. coli shall lose its ability of assimilating prolineif a transposon is inserted into a suitable site of its put gene. For E.coli, therefore, a transposon is introduced thereinto, and a mutant E.coli that has lost its proline decomposition activity also can beselected through a chemical resistance test and a cell-growing test on aPro-TTC plate.

The mutant that has lost its proline decomposition activity due to theintroduction of a transposon thereinto can be subjected to P1transduction to thereby transfer its characteristic not having a prolinedecomposition activity into a different strain.

The thus obtained transformant is cultivated by an ordinary cultivationmethod.

The medium for cultivating these microbial transformants such asEscherichia coli, yeast strains or the like may be any of natural mediaand synthetic media that contain carbon sources, nitrogen sources,inorganic salts, etc. that may be assimilated by the microorganisms.

Any carbon sources that can be assimilated by the microorganisms may beused. Examples of the carbon source include carbohydrates such asglucose, fructose, sucrose, molasses containing these components, starchand starch hydrolyzates; organic acids such as acetic acid and propionicacid; and alcohols such as ethanol and propanol.

As the nitrogen sources, ammonia, ammonium salts of inorganic andorganic acids such as ammonium chloride, ammonium sulfate, ammoniumacetate and ammonium phosphate, other nitrogen-containing compounds,peptone, meat extracts, yeast extracts, corn steep liquor, caseinhydrolyzates, soybean cakes, soybean cake hydrolyzates, culturedfermented cells, their digested products, etc. may be used.

As inorganic salts, potassium dihydrogen phosphate, dipotassium hydrogenphosphate, magnesium phosphate, magnesium sulfate, sodium chloride,ferrous sulfate, manganese sulfate, copper sulfate, calcium carbonate,etc. may be used.

The cultivation is conducted under aerobic conditions, for example, withshaking culture or submerged-aerial stirring culture. The temperaturefor the cultivation is 15 to 40° C. The period for the cultivation isusually 16 to 96 hours. During the cultivation, the pH of the medium iskept at 3.0 to 9.0. The pH is adjusted using inorganic or organic acids,alkaline solutions, urea, calcium carbonate, ammonia or the like.

L-Proline is suitably added to the media in such a manner that itsconcentration may be from 5 to 1000 mM, preferably from 20 to 200 mM,whereby the intended L-proline-4-hydroxylases can be produced moreefficiently.

Antibiotics such as ampicillin, tetracycline or the like may be added tothe medium during the cultivation, if required.

For the cultivation of the microorganisms which are transformed with theexpression vector using the inducible promoter, inducers may be added tothe medium, if required. For example, in cultivation of microorganismstransformed with the expression vector using lac promoter,isopropyl-β-D-thiogalactopyranoside (IPTG) maybe added to the medium. Incultivation of microorganisms transformed with the expression vectorusing trp promoter, indoleacrylic acid (IAA) may be added to the medium.

As the medium for cultivating the transformants which are obtains byusing the animal cells as a host cell, RPMI1640 medium and Eagle's MEMmedium which are generally used or these culture media containing afetal bovine serum can be used.

The cultivation of the cells is conducted in the presence of 5% CO₂. Thetemperature for the cultivation is preferably 35 to 37° C., and theperiod for the cultivation is usually 3 to 7 days.

L-proline is suitably added to the media in such a manner that itsconcentration may be from 5 to 1000 mM, preferably from 20 to 200 mM,whereby the intended L-proline-4-hydroxylases can be produced moreefficiently.

Antibiotics such as kanamycin, penicillin or the like may be added tothe medium during the cultivation, if required.

A considerable amount of L-proline-4-hydroxylase is produced andaccumulated in the thus-cultivated transformants in comparison to themicroorganism strain used as the gene source, such as Dactylosporangiumsp. RH1 or the like. Thus, the isolation and purification of the enzymeor the production of trans-4-hydroxy-L-proline from L-proline using theenzyme can be performed far more efficiently in comparison to theproduction of trans-4-hydroxy-L-proline from L-proline using the nongenetically-engineered microorganism as the gene source, such asDactylosporangium sp. RH1 or the like.

The production of L-proline-4-hydroxylase in the transformants can becarried out by adding the culture, the cells or the treated cells to anaqueous medium suitable for the enzymatic reaction together withL-proline, a divalent iron ion and 2-ketoglutaric acid, and adding asurfactant or an organic solvent, if required, to determinetrans-4-hydroxy-L-proline produced. With respect to the activity of theL-proline-4-hydroxylase of which the formation is confirmed in the cell,the activity of the enzyme for producing 1 nmol oftrans-4-hydroxy-L-proline for 1 minute under the following conditions isdefined as 1 unit (U). The microorganism cells and the animal cells arehere called cells.

Measurement of L-Proline-4-Hydroxylase Activity:

The cells, the treated cells or the enzyme preparation are added to 240mM MES [2-(N-morphorino) ethanesulfonic acid] buffer containing 12 mML-proline, 24 mM 2-ketoglutaric acid, 4 mM ferrous sulfate and 8 mML-ascorbic acid to make 250 μl in total. The mixture is kept at 35° C.for 10 minutes. The reaction mixture is heated at 100° C. for 2 minutesto stop the reaction, and the amount of trans-4-hydroxy-L-prolineproduced in the reaction mixture is determined by HPLC.

For the determination, any method capable of determining the amount oftrans-4-hydroxy-L-proline maybe employed. For instance, generally usableare (1) a post-column derivatization method and (2) a pre-columnderivatization method as mentioned above.

The enzyme may be isolated and purified in a usual manner from theculture of the transformant in which the formation ofL-proline-4-hydroxylase is confirmed in the cultivated cell as mentionedabove. For instance, the culture broth of the transformant iscentrifuged to collect the cultivated cells therefrom, and the cells arewashed and then disrupted by an ultrasonic cell disrupter, a Frenchpress, a Manton-Gauline homogenizer, a Dyno mill or the like to obtain acell-free extract. The purified enzyme prepatarion can be obtained byammonium sulfate precipitation, anion exchange chromatography such asdiethylaminoethyl (DEAE) Sepharose or the like, hydrophobicchromatography such as butyl-Sepharose, phenyl-Sepharose or the like,gel filtration, electrophoresis such as isoelectric pointelectrophoresis, and so on from the supernatant of the cell-free extractobtained by centrifugation.

The cultivated transformant cells that have been identified to containthe L-proline-4-hydroxylase as formed therein can be cultivated underthe same conditions as above, under which the transformant cells werecultivated, to thereby make the cells produce and accumulatetrans-4-hydroxy-L-proline in the cells, and the thus-producedtrans-4-hydroxy-L-proline can be collected from the culture to obtainit.

If the transformant cell derived from host cell which has the ability ofproducing L-proline from saccharide sources and accumulating it in thecultures and where such cells are used, it is possible to producetrans-4-hydroxy-L-proline even if L-proline is not added to the mediaduring the cultivation of the cells therein. However, it is desirable tosuitably add to the media L-proline at a concentration of from 5 to 1000mM, preferably from 20 to 200 mM, whereby the intendedtrans-4-hydroxy-L-proline can be produced more efficiently.

The transformant cells as derived from a transformant host having areinforced proline biosynthesis activity can efficiently producetrans-4-hydroxy-L-proline without adding L-proline thereto.

If the transformant cells have the ability of producing 2-ketoglutaricacid from saccharide sources and accumulating it in the cultures andwhere such cells are used, it is possible to producetrans-4-hydroxy-L-proline even if 2-ketoglutaric acid is not added tothe media during the cultivation of the cells therein. Where suchtransformant cells are used, saccharide sources such as glucose may besuitably added to the media to make the cells produce and accumulate2-ketoglutaric acid in the cultures, whereby the intendedtrans-4-hydroxy-L-proline can be produced more efficiently. Where, onthe other hand, transformant cells not having the ability of producing2-ketoglutaric acid from saccharide sources are used, 2-ketoglutaricacid may be added to the media during the incubation of the cells, ifdesired.

If desired, 2-ketoglutaric acid and divalent iron ions may be added tothe media during the cultivation of the transformant cells.

To produce trans-4-hydroxy-L-proline, also employable is another methodto be mentioned below using, as the enzyme source, the cultures of thetransformant cells where the formation of L-proline-4-hydroxylases hasbeen identified, the cells isolated from the cultures, or the productsas obtained by processing the cells.

The method to produce trans-4-hydroxy-L-proline is as follows. Thecultures of the transformant cells, the cells isolated from the culture,or the products as obtained by processing the cells are added to aqueousmedia suitable for enzymatic reaction, along with L-proline, divalentiron ions and 2-ketoglutaric acid and optionally with surfactants andorganic solvents, thereby converting L-proline intotrans-4-hydroxy-L-proline, and thereafter the resultingtrans-4-hydroxy-L-proline is collected from the reaction mixtures toobtain it.

As examples of the processed cells, dried cells, lyophilized cells,surfactant-treated cells, enzymatically-treated cells,ultrasonically-treated cells, mechanically-ground cells,mechanically-compressed cells, solvent-treated cells, fractionated cellproteins, immobilized cells, immobilized materials obtained byprocessing their cells, etc. can be used. The enzyme preparationobtained by extraction from the cells having L-proline-4-hydroxylaseactivity, purified products of these enzymes, and immobilized productsthereof can also be used.

As examples of the aqueous medium, water, buffers such as phosphates,carbonates, acetates, borates, citrates and tris-buffers, alcohols suchas methanol and ethanol, esters such as ethyl acetate, ketones such asacetone, and amides such as acetamide can be mentioned.

As examples of the surfactant, cationic surfactants such aspolyoxyethylene-stearylamine (for example, Nymeen S215 produced byNippon Oils & Fats Co.), cetyltrimethylammonium bromide, Cation FB,Cation F2-40E, etc.; anionic surfactants such as sodiumoleylamidosulfate, Newrex TAB, and Rapizole 80.; ampholytic surfactantssuch as polyoxyethylene-sorbitan monostearate (for example, NonionST221) or the like.; and also other tertiary amines PB,hexadecyldimethylamine, etc. can be mentioned. Any and every surfactantthat promotes the reaction may be employed. The concentration of thesurfactant is usually from 0.1 to 50 mg/liter, preferably from 1 to 20mg/liter.

As examples of the organic solvent, toluene, xylene, aliphatic alcohols,benzene and ethyl acetate can be mentioned. The concentration of theorganic solvent is usually from 0.1 to 50 μl/ml, preferably from 1 to 20μl/ml.

The reaction may be conducted during the cultivation of the transformanthaving the activity of L-proline-4-hydroxylase, or may also be conductedafter the completion of the cultivation, in the aqueous medium using thecells, the treated cells, the purified enzyme or the crude enzymeprepared from the culture.

The amount of the enzyme added to the reaction mixture is determineddepending on the amount of the substrate used. Usually, it may be from1.0 to 10,000,000 U/liter, preferably from 1,000 to 3,000,000 U/liter ofthe aqueous medium. In case of using the cells or the treated cells ofthe microorganism, the concentration of wet cells is usually from 1 to300 g/liter.

The reaction is usually conducted at a temperature from 15 to 50° C. ata pH from 6.0 to 9.0 for 1 to 96 hours.

The concentration of L-proline used in the reaction may be from 1 mM to2 M. L-Proline can be supplied by adding L-proline itself to thereaction mixture, or adding the culture of the microorganism which canproduce and accumulate L-proline from sugar source. Further, if amicroorganism having the ability of producing L-proline from a sugarsource is used as the host microorganism of the transformant, L-prolineproduced from a sugar source by the host microorganism can be used inthe reaction. That is, L-proline produced by the transformant derivedfrom the host microorganism having the ability of producing L-proline isconverted into trans-4-hydroxy-L-proline in the culture broth usingL-proline-4-hydroxylase produced by the transformant, wherebytrans-4-hydroxy-L-proline can be produced in the culture without theaddition of L-proline.

The divalent iron ion is required for the reaction. This divalent ironion is ordinarily used in a concentration of from 1 to 100 mM. Anydivalent iron ion can be used so long as does not inhibit the reaction.As examples of the divalent iron ion, sulfates such as ferrous sulfate;chlorides such as ferrous chloride; ferrous carbide; and organic acidsalts such as citrates, lactates and fumarates can be mentioned. Whenthe divalent iron ion is contained in the cells, the treated cells orthe reaction mixture, the divalent iron need not be added.

2-Ketoglutaric acid itself may be added to the reaction mixture or maybe supplied from a compound which can be converted into 2-ketaglutaricacid by the metabolic activity of the cells or the treated cells used.As examples of such a compound, saccharides such as glucose; amino acidssuch as glutamic acid; and organic acids such as succinic acid can bementioned. These compounds may be used singly or in combination.

Trans-4-hydroxy-L-proline is recovered from the culture or the aqueousmedium by any ordinary separation method, for example, columnchromatography using an ion-exchange resin, etc. by crystallization,etc.

The structure of the thus-recovered trans-4-hydroxy-L-proline can beidentified by ordinary analytical method such as ¹³C-NMR spectrum,¹H-NMR spectrum, mass spectrum, specific rotation or the like.

The trans-4-hydroxy-L-proline produced by the present invention can bedetermined quantitatively by the above-mentioned post-columnderivatization method or pre-column derivatization method.

The present invention is illustrated more specifically by referring tothe following Examples.

EXAMPLE 1

(1) Production of Trans-4-Hydroxy-L-Proline by Dactylosporangium sp. RH1

SR3 medium comprising 1.0% glucose, 1.0% soluble starch, 0.5% yeastextract, 0.5% tryptone, 0.3% meat extract and 0.05% magnesium phosphatewas adjusted to pH 7.2 with 6N NaOH, was put in test tubes (diameter 25mm×length 200 mm) in an amount of 10 ml each and sterilized at 120° C.for 20 minutes. One loopful of cells of Dactylosporanqium sp. RH1, thathad grown in HT-agar plate medium comprising 1% soluble starch, 0.2% NZamine, 0.1% yeast extract, 0.1% meat extract and 1.5% agar, adjusted to7.2 with 6N NaOH, and sterilized at 120° C. for 20 minutes, wasinoculated into the above-mentioned SR3 medium in each test tube,cultivated at 28° C. for 2 days with shaking. The resulting culture wasused as a seed culture in the following steps.

Separately, Df1 medium comprising 5% soluble starch, 1.5% soybean meal,0.05% monopotassium phosphate, 0.05% magnesium sulfate 7 hydrate and0.5% calcium carbonate, and adjusted to pH 7.0 with 6N NaOH, was put intest tubes (diameter 25 mm×length 200 mm) in an amount of 10 ml each andsterilized at 120° C. for 20 minutes. One ml of the above-mentioned seedculture was inoculated in the medium in each test tube under germ-freecondition and cultivated at 28° C. for 2 days with shaking. Thethus-obtained culture was centrifuged at 7000× g for 10 minutes at 4° C.The cells thus separated were washed with 80 mM TES [N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid] buffer (pH 7.5) andthen recentrifuged. 150 mg of the thus-obtained wet cells was suspendedin 1.5 ml of a reaction mixture which had been prepared by adding 1.4%(v/v) of Nymeen solution [prepared by adding 4 g of Nymeen S-215(produced by Nippon Oils & Fats Co.) to 0 ml of xylene] to 80 mM TESbuffer (pH 7.5) containing 4 mM L-proline, 8 mM 2-ketoglutaric acid, 4mM L-ascorbic acid and 2 mM ferrous sulfate] and the mixture was allowedto stand at 30° C. for 2 hours to carry out the enzymatic reaction.

After the reaction, the cells were removed from the reaction mixture bycentrifugation, and the amount of trans-4-hydroxy-L-proline produced inthe supernatant was determined.

The determination was carried out by a post-column derivatization methodby HPLC under the conditions mentioned below. To identify the intendedproduct, the resulting product was eluted from the column and reactedwith NBD in the column line to form its NBD-derivative and thederivative was determined by fluorophotometry.

Conditions for Determination by HPLC

[1] Apparatus Used

High Performance Liquid Chromatography Device (produced by ShimadzuSeisakusho K.K.)

Chromatopac CR6A System controller SCL-6B Autoinjector SIL-6B LiquidChromatograph Pump LC-6A Column Oven CTO-6A Chemical Reaction Box CRB-6ASpectrofluorometric Detector RF-550A

[2] Column Used:

SUMCHIRAL OA5000 (diameter 4.5 mm×length 250 mm, produced by SumikaChemical Analysis Service Limited)

[3] Conditions for Analysis:

1) Mobile Phase: aqueous 1 mM solution of copper sulfate 2) Flow Rate ofMobile Phase:   1.0 ml/min 3) Column Temperature: 38° C. 4) Buffer: 0.3M boric acid buffer (pH 9.6) 25 mM ethylenediaminetetraacetic acid 5)Flow Rate of Buffer: 0.2 ml/min 6) NBD Solution: methanol 0.5 g/litersolution of 7) Flow Rate of NBD Solution: 0.5 ml/min 8) ReactionTemperature: 60° C. 9) Reaction Time: about 3 min 10) Wavelength forDetection: excitation wavelength 503 nm emission wavelength 541 nm 11)Sample:  10 μl

As a result of the determination, it was verified that 249 μM (32.6mg/liter) of trans-4-hydroxy-L-proline was produced in the reactionmixture.

(2) Production of Trans-4-Hydroxy-L-Proline by Dactylosporangium sp. RH1

SR3 medium was put into a test tube in amount of 10 ml and sterilized at120° C. for 20 minutes. One loopful of cells of Dactylosporangium sp.RH1 that had grown in an HT-agar plate medium were inoculated in themedium and cultivated at 28° C. for 2 days with shaking. The culturethus prepared was used as a seed culture.

Df3 medium was put into another test tube in amount of 10 ml andsterilized at 120° C. for 20 minutes. One ml of the seed cultureprepared above was inoculated in the Df3 medium under germ-freeconditions and cultivated at 28° C. for 2 days with shaking. Theresulting culture was centrifuged at 8000 rpm and at 4° C. for 10minutes. The cells thus separated were washed with 80 mM TES buffer (pH7.5) and then centrifuged. 150 mg of the wet cells thus obtained weresuspended in 1.5 ml of a reaction mixture [which is 80 mM TES buffer (pH7.5) comprising 4 mM L-proline, 8 mM α-ketoglutaricacid, 4 mM L-ascorbicacid and 2 mM ferrous sulfate, to which was added 1.4% (v/v) of Nymeensolution (which is prepared by dissolving 4 g of Nymeen S-215 (producedby Nippon Oils & Fats Co.) in 10 ml of xylene)] and reacted at 30° C.for 30 minutes. After the reaction, the cells were separated from thereaction mixture through centrifugation, and the amount ofhydroxyproline formed in the supernatant was quantitatively determined,from which the L-proline-4-hydroxylase activity of the cells ofDactylosporangium sp. was determined.

As a result of the determination, it was verified that 84 μM (11.0mg/liter) of trans-4-hydroxy-L-proline was produced in the reactionmixture. The L-proline-4-hydroxylase activity of the cell was 0.028 U/mgwet cells/min.

EXAMPLE 2

Purification of Trans-4-Hydroxy-L-Proline

The seed cultivation was carried out in the same manner as in (1) ofExample 1, using 2 liter Erlenmeyer flasks each containing 200 ml of SR3medium. Df1 medium was put in 5 liter jar fermenters in an amount of 2liters each and sterilized at 120° C. for 20 minutes. The seed culturewas inoculated in the Df1 medium in each jar fermenter under germ-freecondition and cultivated under the condition of 700 rpm and 1 vvm, at28° C. for 2 days. During the cultivation, the pH of the medium was notadjusted. The thus-obtained culture medium was centrifuged at 7,000× gfor 10 minutes at 4° C. to obtain wet cells in an amount of 75 g perliter of the culture. A part of the wet cells was washed with aphysiological saline at 4° C. and recentrifuged. If desired, thethus-obtained wet cells were frozen and stored at −80° C., and thefrozen cells were thawed before use.

Separately, 400 g of the wet cells was suspended in 2 liters of thereaction mixture described in Example 1, put in a 3 liter beaker, andthe enzymatic reaction was carried out at 30° C. for 4 hours withstirring.

After the reaction, the cells were removed from the reaction mixture bycentrifugation, and trans-4-hydroxy-L-proline produced in thesupernatant was determined. It was verified that 480 μm (63.0 mg/liter)of trans-4-hydroxy-L-proline was produced in the reaction mixture.

The reaction mixture was adjusted to pH 4.5, and the supernatantseparated from the reaction mixture was passed through a column packedwith 200 ml of an ion-exchange resins Diaion SKIB (NH₄ ⁺ type, producedby Mitsubishi Kasei Corp.). The fraction containingtrans-4-hydroxy-L-proline was concentrated under reduced pressure andthen passed through a column packed with 20 ml of an ion-exchange resin,Diaion PA412 (OH-type, produced by Mitsubishi Kasei Corp.). The fractioncontaining trans-4-hydroxy-L-proline was concentrated under reducedpressure, and adjusted to pH 9.6. 10 volume % of o-phthal aldehyde(hereinafter referred to as OPA) solution (0.075 g of OPA/ml ethanolsolution) and 2 volume % of β-mercaptoethanol solution (10% v/v aqueoussolution) were added thereto. The mixture was then allowed to stand at60° C. for 5 minutes, whereby impurities of primary amino acidscontained therein were reacted with OPA. The resulting mixture waspassed through a column packed with 10 ml of Sepabeads SP207 (producedby Mitsubishi Kasei Corp.), to separate trans-4-hydroxy-L-proline fromthe impurities of OPA-derivatized primary amino acids. The fractioncontaining trans-4-hydroxy-L-proline was concentrated under reducedpressure and again passed through a column packed with 20 ml of anion-exchange resin, Diaion PA412 (OH-type, produced by Mitsubishi KaseiCorp.) to separate a fraction containing trans-4-hydroxy-L-proline. Thefinal fraction was concentrated and dried to obtain 78 mg of whitecrystals of trans-4-hydroxy-L-proline. The yield of the product was 62%.The white crystals were analyzed, and the data of its ¹³C-NMR spectrum,¹H-NMR spectrum, mass spectrum and specific rotation were found tocoincide with a standard sample of trans-4-hydroxy-L-proline (producedby Nacalai Tesque Co.).

EXAMPLE 3

(1) Production of Trans-4-Hydroxy-L-Proline by Amycolatopsis sp. RH2

SR3 medium was put in test tubes (diameter 25 mm×length 200 mm) in anamount of 10 ml each and sterilized at 120° C. for 20 minutes. Oneloopful of cells of Amycolatopsis sp. RH2 that had grown in HT-agarplate medium was inoculated in the above-mentioned medium in each testtube, cultivated at 28° C. for 2 days with shaking, and used as a seedculture in the following steps.

Separately, Df1 medium was put in test tubes (diameter 25 mm×length 200mm) in an amount of 10 ml each and sterilized at 120° C. for 20 minutes.One ml of the seed culture was inoculated in the medium in each testtube under germ-free condition and cultivated at 28° C. for 2 days withshaking. The thus-obtained culture was centrifuged at 7000× g for 10minutes at 4° C. The cells thus separated were washed with 100 mM TESbuffer (pH 7.5) and then recentrifuged. In 1.5 ml of a reaction mixturewhich had been prepared by adding 1.4% (v/v) of Nymeen solution[prepared by adding 4 g of Nymeen S-215 (produced by Nippon Oils & FatsCo.) to 10 ml of xylene] to 100 mM TES buffer (pH 7.5) containing 5 mML-proline, 5 mM 2-ketoglutaric acid, 5 mM L-ascorbic acid and 1 mMferrous sulfate, 100 mg of the thus-obtained wet cells was suspended andthe mixture was allowed to stand at 30° C. for 3 hours.

After the reaction, the cells were removed from the reaction mixture bycentrifugation, and hydroxyprolines produced in the supernatant weredetermined.

The determination of trans-4-hydroxy-L-proline was conducted in the samemanner as in Example 1.

It was verified that 25 μM (3.3 mg/liter) of trans-4-hydroxy-L-prolinewas produced in the reaction mixture.

(2) Production of Trans-4-Hydroxy-L-Proline by Streptomyces

The amount of trans-4-hydroxy-L-proline and the L-proline-4-hydroxylaseactivity of Streptomyces griseoviridis JCM4250 and Streptomycesdaghestanicus JCM4365 was determined in the same manner as in (2) ofExample 1. In this example, however, a Df4 medium [comprising 2.5% ofglycerol, 2.S % of glucose, 1.5% of soybean meal, 0.005% ofmonopotassium phosphate, 0.05% of magnesium sulfate 7-hydrate and 0.5%of calcium carbonate and adjusted to pH 7.0 with 6N NaOH] was used inplace of the Df1 medium.

As a result of the determination, it was verified that 60 μM oftrans-4-hydroxy-L-proline was produced in the reaction mixture when thecells of Streptomyces griseoviridis JCM4250 was used. TheL-proline-4-hydroxylase activity of the cell was 0.020 U/mg wetcells/min. The amount of trans-4-hydroxy-L-proline and theL-proline-4-hydroxylase activity of Streptomyces daghestanicus JCM4365were 27 μM and 0.009 U/mg wet cells/min, respectively.

EXAMPLE 4

Purification of Trans-4-Hydroxy-L-Proline

The seed cultivation was carried out in the same manner as in (1) ofExample 3, using 2 liter Erlenmeyer flasks each containing 200 ml of SR3medium. Df1 medium was put in 5 liter jar fermenters in an amount of 2liters each and sterilized at 120° C. for 20 minutes. The seed culturewas inoculated in the Df1 medium in each jar fermenter under germ-freecondition and cultivated under the condition of 700 rpm and 1 vvm, at28° C. for 2 days. During the cultivation, the pH of the medium was notadjusted. The thus-obtained culture medium was centrifuged at 7,000× gfor 10 minutes at 4° C. to obtain wet cells in an amount of 75 g perliter of the culture. In 2 liters of the reaction mixture described inExample 3, 400 g of the wet cells were suspended, and put in a 3 literbeaker, and the reaction mixture was allowed to stand at 30° C. for 4hours with stirring.

The supernatant was adjusted to pH 4.5, and passed through a columnpacked with 200 ml of an ion-exchange resin, Diaion SK18 (NH₄ ⁺ type,produced by Mitsubishi Kasei Corp.). The fraction containingtrans-4-hydroxy-L-proline was concentrated under reduced pressure andthen passed through a column packed with 20 ml of an ion-exchange resin,Diaion PA412 (OH-type, produced by Mitsubishi Kasei Corp.). The fractioncontaining trans-4-hydroxy-L-proline was concentrated under reducedpressure, adjusted to pH 9.6, and 10 volume % of OPA solution (0.075g/ml ethanol solution) and 2 volume % of β-mercaptoethanol solution (10%v/v aqueous solution) were added thereto. The mixture was then allowedto stand at 60° C. for 5 minutes, whereby impurities of primary aminoacids contained therein were reacted with OPA. The resulting mixture waspassed through a column packed with 10 ml of Sepabeads SP207 (producedby Mitsubishi Kasei Corp.), to separate trans-4-hydroxy-L-proline fromthe impurities of the OPA-derivatized primary amino acids. The fractioncontaining trans-4-hydroxy-L-proline was concentrated under reducedpressure and again passed through a column packed with 20 ml of anion-exchange resin, Diaion PA412 (OH-type, produced by Mitsubishi KaseiCorp.) to separate a fraction containing trans-4-hydroxy-L-proline. Thefinal fraction was concentrated and dried to obtain 4.8 mg of whitecrystals of trans-4-hydroxy-L-proline. The yield of the product was 62%.

The white crystals were analyzed, and the data of its ¹³C-NMR spectrum,¹H-NMR spectrum, mass spectrum and specific rotation were found tocoincide with those of a standard sample of trans-4-hydroxy-L-proline(produced by Nacalai Tesque Co.).

EXAMPLE 5

Isolation and Purification of L-Proline-4-Hydroxylase

(1) Preparation of Cell-Free Extract

Six hundred grams of the wet cells obtained in Example 2 was suspendedin 3 liters of Buffer A [50 mM TAPS buffer (pH 9.0) containing 2 mM DTT,0.2 mM EDTA and 20% (v/v) of glycerol] while cooling with ice. Theresulting suspension was milled by a Dyno-mill (produced by Willy ABachofen Maschinenfabrik, Basel, Switzerland) to disrupt the cells. Thethus-disruped cell suspension was subjected to centrifugation at 6,500×g at 4° C. for 30 minutes to separate the supernatant.

The subsequent operations were conducted under cooling with ice at atemperature of 4° C. or lower.

(2) Isolation and Purification by Various Types of Column Chromatography

(2)-1 STREAMLINE

The supernatant obtained in the previous step was passed through aSTREAMLINE™ (produced by Pharamacia Co.) filled with 300 ml of DEAEadsorbent that had been equilibrated with Buffer A, whereupon a fractioncontaining the L-proline-4-hydroxylase was eluted with Buffer Acontaining 0.3M NaCl.

(2)-2 DEAE Sepharose Column Chromatography

The active fraction obtained in the previous step was diluted threetimes with Buffer A and passed through a DEAE Sepharose column (5 cm×15cm) that had been equilibrated with Buffer A. The column was washed withBuffer A, and the fraction containing the enzyme was eluted with BufferA having a linear concentration gradient of NaCl of 0 to 0.3M.

(2)-3 Butyl Sepharose Column Chromatography

NaCl was added to the active fraction obtained in the previous stepuntil an NaCl concentration was 3M. The mixture was passed through abutyl Sepharose column (Butyl Sepharose 4 Fast Flow, 2.6 cm×13 cm) thathad been equilibrated with Buffer A containing 3M NaCl. The enzyme wasstepwise eluted with four kinds of buffers each having a different NaClconcentration, Buffer A containing 3M NaCl, Buffer A containing 1.98MNaCl, Buffer A containing 0.99M NaCl and Buffer A containing no NaCl, inthis order or from the eluent buffer having a higher NaCl concentrationto that having a lower NaCl concentration.

(2)-4 Phenyl Sepharose Column Chromatography

NaCl was added to the active fraction obtained in the previous stepuntil the concentration of NaCl was 3M. The mixture was passed through aphenyl Sepharose column (Phenyl Sepharose HP Hiload 16/10, 1.6 cm×10 cm)that had been equilibrated with Buffer A containing 3M NaCl. The columnwas washed with Buffer A containing 3M NaCl, and the fraction containingthe enzyme was eluted with Buffer A.

(2)-5 Dye Affinity Column Chromatography

The active fraction obtained in the previous step was de-salted, using aPD-10 column (produced by Pharmacia Co.), and the resulting fraction waspassed through a Reactive Red 120 column (1 cm×12.7 cm; produced bySigma Co.) that had been equilibrated with Buffer A. The column waswashed with Buffer A, and the fraction containing the enzyme was elutedwith Buffer A having a linear concentration gradient of NaCl of 0 to1.5M.

(2)-6 Resource Q Column Chromatography

The active fraction obtained in the previous step was de-salted, using aPD-10 column (produced by Pharmacia Co.) that had been equilibrated withBuffer B [50 mM TAPS buffer (pH 8.0) containing 2 mM DTT, 0.1% (v/v) ofTween 20 and 20% (v/v) of glycerol], and the resulting fraction waspassed through a RESOURCE^(TH) Q column (1 ml; produced by PharmaciaCo.) that had been equilibrated with Buffer B. The fraction containingthe enzyme was eluted with Buffer B having a liner concentrationgradient of NaCl of 0 to 0.2M.

Summaries of the isolation and purification of theL-proline-4-hydroxylase are shown in Table 5.

TABLE 5 Summaries of Isolation and Purification ofL-proline-4-hydroxylase Relative Total Total Activity Protein Activity(U/mg of Yield Fraction (mg) (U) protein) (%) Cell-free 13,330 11,0000.83 100 Extract STREAMLINE 4,875 4,880 1.00 44.4 DEAE Sepharose 3533,820 10.8 34.7 Eutyl 35.1 1,310 37.3 11.9 Sepharose Phenyl 1.44 814565.3 7.4 Sepharose Color Affinity 0.212 366 1,726 3.3 Resource Q 0.100384 3,840 3.5

EXAMPLE 6

Properties of L-Proline-4-Hydroxylase

(1) Analysis by Electrophoresis

The purified enzyme preparation obtained in Example 5 was analyzed bysodium dodecylsulfate-polyacrylamide gel electrophoresis (usingpolyacrylamide gel PAGEL NPU-12.5L produced by Atto Co. and SDS-PAGEMolecular Weight Standard, Broad Range produced by Biorad Co.). As aresult, it was verified that the enzyme was composed of almosthomogeneous sub-units having a molecular weight of about 32,000±5,000daltons.

(2) Properties Relating to Enzyme Reaction

The enzyme was subjected to substrate omission and addition tests usingthe reaction mixtures mentioned below, to investigate the compoundsindispensable to the enzyme reaction of the enzyme for hydroxylating the4-position of L-proline, the promoters for the reaction and theinhibitors against the reaction.

The reaction mixture was composed of 80 mM TES buffer (pH 7.5), 4mML-proline, 8 mM 2-ketoglutaric acid, 2 mM ferrous sulfate, 4 mML-ascorbic acid, 2 mg/ml catalase and a pre-determined amount of thepure enzyme, the total volume being 500 μl. The reaction was initiatedby addition of the enzyme and continued for 15 minutes at 30° C. Thereaction was stopped by heating the reaction mixture at 100° C. for 2minutes. The amount of trans-4-hydroxy-L-proline formed in the reactionmixture was determined by the pre-column derivatization method. Onehundred microliter of 0.3M boric acid buffer (pH 10.7), 4 μl of aqueoussolution of 10% (v/v) mercaptoethanol and 16 μl of ethanol solution of5% (w/v) OPA were added to 100 μl of the reaction mixture, and themixture was allowed to stand at 60° C. for 30 seconds. In addition, 50μl of ethanol solution of 2% (W/V) NBD was added thereto and the mixturewas allowed to stand at 60° C. for 40 minutes. The reaction was stoppedby adding 30 μl of 1 N HCl to the reaction mixture, and the precipitatesformed were removed therefrom by centrifugation and filtration. Thetrans-4-hydroxy-L-proline formed by the reaction was quantitativelydetermined by HPLC analysis.

The HPLC for the determination was carried out under the followingconditions:

Mobile Phase: 10 mM Citric Acid (pH 4.0)/Methanol=3/1 (v/v)

Flow Rate: 1 ml/min

Column: YMC Pack ODS AQ-312 (produced by YMC Co., 6×150 mm)

Column Temperature: 50° C.

Detection: Fluorophotometry (excitation wavelength: 503 nm, emissionwavelength: 541 nm)

The test results verified that L-proline, 2-ketoglutaric acid and Fe⁺⁺ion are indispensable for the enzyme reaction for hydroxylatingL-proline at the 4-position of L-proline, that L-ascorbic acid promotesthe reaction and that Zn⁺⁺ ion, Cu⁺⁺ ion and EDTA inhibit the reaction.

The test results are shown in Table 6.

TABLE 6 Investigation of Components Influencing Enzyme Reaction ofL-Proline-4-Hydroxylase Components in Added (+)²⁾ Relative ReactionMixture Not Added(−) Activity³⁾ Basic Reaction 100 Mixture¹⁾ − PureEnzyme 0 − L-Proline 0 − 2-Ketoglutaric Acid 0 − Fe⁺⁺ 0 − L-AscorbicAcid 51 − Catalase 93 + 5 mM EDTA 0 + 1 mM Zn⁺⁺ 6 + 1 mM Cu⁺⁺ 13 ¹⁾Thestandard reaction mixture was 80 mM TES buffer (pH 7.5) containing 4 mML-proline, 8 mM 2-ketoglutaric acid, 2 mM ferrous sulfate, 4 mML-ascorbic acid, 2 mg/ml catalase and a pre-determined amount of thepure enzymer the total volume being 500 μl. The reaction was carried outat 30° C. for 15 minutes. ²⁾“(+)” means that the reaction mixturecontained the component shown in the table. “(−)” means that thereaction mixture did not contain the component shown in the table. Theconcentration shown in the table means the concentration of thecomponent in the reaction mixture. ³⁾The activity is indicated asrelative activity to the activity in the standard reaction mixture ofbeing defined as 100.

(3) Optimum pH Range

In the above-mentioned method of determining the enzyme activity of theL-proline-4-hydroxylase, the reaction was conducted while the buffercomponent in the reaction mixture was changed to sodium acetate bufferat pH of 3.5 to 5.5, it was changed to MES buffer at pH of 5.5 to 6.50,it was changed to TES buffer at pH of 7.0 to 7.5, it was changed to TAPSbuffer at pH of 8.0 to 9.0, and it was changed to CAPSO buffer at pH of9.5 to 11.0. As a result, the enzyme had an activity of more than 90% ofthe maximum activity thereof at pH ranging from pH 6.0 to pH 7.0. Thedetailed test results are shown in Table 7.

TABLE 7 Optimum PH Range for the Enzyme Reaction pH Relative Activity¹⁾3.5 2.9 4.0 4.4 4.5 5.9 5.0 10.3 5.5 41.2 6.0 97.0 6.5 100.0 7.0 91.27.5 75.0 8.0 47.1 8.5 44.0 9.0 29.4 9.5 7.4 10.0 4.4 10.5 0 11.0 0 ¹⁾Theactivity is indicated as relative activity to the activity in pH6.5 ofbeing 100.

(4) Stable pH Range

The enzyme was kept in the presence of 50 mM of a buffer (sodium acetatebuffer at pH of 3.5 to 5.5, MES buffer at pH of 5.5 to 6.5, TES bufferat pH of 7.0 to 7.5, TAPS buffer at pH of 8.0 to 9.0, CAPSO buffer at pHof 9.5 to 11.0), 2 mM DTT and 20% (v/v) of glycerol, at 4° C. for 24hours, and then its activity was determined. The enzyme kept at pHranging from 6.5 to 10.0 had an activity of 90% or more of the originalactivity of the enzyme before the test. Accordingly, the enzyme was keptstable at pH ranging from 6.5 to 10.0.

(5) Optimum Temperature Range

In the above-mentioned method of determining the enzyme activity of theL-proline-4-hydroxylase, the reaction was carried out at temperaturesranging from 15 to 50° C. for 15 minutes. As a result, the enzyme had anactivity of 90% or more of the maximum activity thereof at temperaturesranging from 30 to 40° C. The detailed test results are shown in Table8.

TABLE 8 Optimum Temperature Range for the Enzyme Reaction ReactionTemperature (° C.) Relative Activity¹⁾ 15 28 20 41 25 60 30 91 35 100 4096 45 68 50 32 ¹⁾The Activity is indicated as a relative activity to themaximum activity of being defined as 100.

(6) Stable Temperature Range

The enzyme was kept in 50 mM TAPS buffer (pH 9.0) containing 2 mM DTT,0.1% (v/v) of Tween 20 and 20% (v/v) of glycerol at a temperatureranging from 0 to 60° C. for 30 minutes and thereafter the activity ofthe enzyme was determined. As a result, the enzyme was inactivated at50° C. or higher for 30 minutes.

(7) N-Terminal Amino Acid Sequence

The enzyme was analyzed, using Protein Sequencer Model PPSQ-10 (producedby Shimadzu Seisakusho K.K.), to determine the N-terminal amino acidsequence of the enzyme. The result was as follows:

Sequence No. 1: (N-terminal)  1 MetLeuThrProThrGluLeuLysGlnTyr 11ArgGluAlaGlyTyrLeuLeuIleGluAsp 21 GlyLeuGlyProArgGluVal

EXAMPLE 7

Production of Trans-4-Hydroxy-L-Proline

The enzyme reaction with purified L-proline-4-hydroxylase obtained inExample 5 was carried out. The reaction mixture was composed of 200 mMMES buffer (pH 6.5), 20 mM L-proline, 20 mM 2-ketoglutarate, 5 mML-ascorbic acid, 2 mM ferrous sulfates and 90 U of purified enzymepreparation in total volume of 50 μl. The reaction was carried out at35° C. for 30 min. As a result of the reaction, 12.9 mM (1.7 g/1) oftrans-4-hydroxyL-proline was produced in the reaction mixture.

EXAMPLE 8

Preparation of Partial DNA Fragment of the Gene EncodingL-Proline-4-Hydroxylase Protein Derived from Dactylosporangium sp. RH1

(1) Isolation of Chromosomal DNA of Dactylosporangium sp. RH1

Chromosomal DNA of Dactylosporanaium sp. RH1 was isolated in the usualmanner as follows. SK#2 medium (comprising 0.25% glucose, 1.0% solublestarch, 0.25% yeast extract, 0.25% peptone, 0.15% meat extract, 0.01%potassium dihydrogen phosphate and 0.03% magnesium sulfate, and adjustedto pH 7.6 with 6N NaOH) containing 5% mannitol and 0.05% glycine, wasput into test tubes in an amount of 10 ml each, and sterilized at 120°C. for 20 minutes. One loopfui of cells of Dactylosporangium sp. RH1which had grown in TH-agar plate medium (comprising 1% soluble starch,0.2% NZ amine, 0.1% yeast extract, 0.1% meat extract and 1.5% agar,adjusted to pH7.2 with 6N NaOH and sterilized at 120° C. for 20minutes), was inoculated in the above-mentioned medium, and cultivatedat 28° C. for 3 days with shaking.

The culture was centrifuged, and the obtained cells were washed with 10ml of a 10.3% sucrose solution, and suspended in 6 ml of TS comprising10.3% sucrose, 50 mM tris.HCl (pH 8.0) and 25 mM EDTA. One milliliter ofa lysozyme solution (50 mg/ml·TS) was added thereto, and the mixture wasincubated at 37° C. for 60 minutes. Subsequently, 0.6 ml of a ProteinaseK (produced by Sigma Co.) solution (2 mg/ml·TS) was added to thelysozyme-treated solution, and gently stirred. Further, 3.6 ml of a 3.3%(w/v) SDS solution was added thereto while gently mixing, and themixture was incubated at 37° C. for 60 minutes. The mixture was heatedat 50° C. for 30 minutes, and then cooled with water. An equal amount ofTE [containing 10 mM tris.HCl (pH 8.0) and 1 mM EDTA] saturatedphenol-chloroform (1/1, v/v) was added thereto, and the mixed solutionwas moderately shaked for 30 minutes. After the centrifugation, theupper layer was taken, and again subjected to extraction with themixture of TE saturated phenol-chloroform. The extract was centrifuged,and an equal amount of chloroform was then added to the upper layer, andmixed. The mixture was recentrifuged. The upper layer was taken, and 20μl of an RNase A aqueous solution (10 mg/ml) heat-treated at 100° C. for10 minutes was added to the upper layer. The mixture was incubated at37° C. for 45 minutes. To the RNase A-treated solution were added{fraction (1/10)} volume of a 5 M NaCl aqueous solution and ¼ volume of50% PEG6000, and gently mixed. The mixture was allowed to standovernight while being cooled with ice. After the mixed solution wascentrifuged at 12,000 rpm for 10 minutes, the supernatant was discardedcompletely, and the precipitate was dissolved in 5 ml of TE. After{fraction (1/10)} volume of a 3 M sodium acetate solution and {fraction(1/30)} volume of a 66 mM magnesium chloride solution were added theretoand mixed, 2.2 volumes of cold ethanol was added, and gently mixed.After the mixed solution was centrifuged at 10,000 rpm for 10 minutes,the supernatant was discarded, and the precipitate was washed twice with70% cold ethanol. The precipitate containing 250 μg of chromosomal DNAwas dissolved in TE and used in the subsequent experiment as chromosomalDNA.

(2) Preparation of Partial DNA Fragment of L-Proline-4-Hydroxylase Gene

The sense strand mixed DNA primer indicated in Sequence No. 4corresponding to amino acids Nos. 1 to 6 of an amino acid sequenceindicated in Sequence No. 1 and an anti-sense strand mixed DNA primerindicated in Sequence No. 5 corresponding to amino acids Nos. 19 to 24indicated in Sequence No. 1 were synthesized using 38OA•DNA Synthesizermanufactured by Applied Biosystems.

Using the above-synthesized DNA primers and Dactylosporangium sp. RH1chromosomal DNA as a template, the PCR was conducted by a Program TempControl System PC-700 manufactured by K.K. Astec. The reaction wasconducted using 20 μl of a reaction mixture having the followingformulation.

Formulation of the reaction mixture:

Dactylosporangium sp. RH1 chromosomal DNA - 22 ng/μl sense strand mixedDNA primer - 10 μM anti-sense strand mixed DNA primer - 10 μM Pfu DNApolymerase produced by Stratagene - 0.125 U/μl DMSO - 10% tris · HC1 (pH8.2) - 20 mM KCl - 10 mM ammonium sulfate - 6 mM magnesium chloride - 2mM Triton X-100 - 0.1% bovine serum albumin - 10 ng/μl

After the completion of an incubation at 96° C. for 5 minutes, a threestep incubation, namely at 96° C. for 2 minutes, at 37° C. for 1 minuteand at 72° C. for 1 minute was repeated for a total of five times.Further, a three step incubation, namely at 96° C. for 2 minutes, at 50°C. for 1 minute and at 72° C. for 1 minute was repeated for a total of35 times. The reaction mixture was subjected to electrophoresis with 15%polyacrylamide (PAGEL NPU-15L produced by Atto Co.), and a band of 71 bpwas recovered using da Vinci Kun (Pen Touch Recovery NB-7000 Model)manufactured by Nippon Eido K.K. The recovered DNA fragment (71 bp) wasinserted into a Sma I site of pUC18 using a Sure Clone Ligation Kitproduced by Pharmacia Co., and the nucleotide sequence was determined bya nucleotide sequencing kit (Taq DyeDeoxy™ Terminator Cycle SequencingKit produced by Applied Biosystems). The determined nucleotide sequenceof the DNA fragment of 71 bp is shown in Sequence No. 6. The amino acidsequence presumed from the nucleotide sequence of the DNA fragment of 71bp completely agreed with the N-terminal amino acid sequence of thepurified enzyme indicated in Sequence No. 1.

EXAMPLE 9

Cloning of a DNA Fragment Containing L-proline-4-Hydroxylase Gene

(1) Preparation of a DIG Probe

A digoxigenin (DIG) labeled DNA fragment of 71 bp was prepared using aPCR DIG Labelling Kit produced by Boehringer Mannheim.

The PCR was conducted using 2.5 U of Pfu DNA Polymerase (produced byStratagene), 5 μl of ×10 Buffer for Pfu DNA polymerase (produced byStratagene), 5 μl of DMSO, 5 μl of ×10 PCR DIG Mix (produced byBoehringer Mannheim), 1 μl of a dilute solution obtained by diluting toten times the DNA solution containing the fragment of 71 bp formed inthe PCR and recovered after the electrophoresis with polyacrylamide gelin (2) of Example 8, and 50 μl of a reaction mixture containing 10 μM ofthe sense strand synthetic DNA indicated in Sequence No. 4 and 10 μM ofthe anti-sense strand synthetic DNA indicated in Sequence No. 5. Afterthe completion of an incubation at 96° C. for 5 minutes, a three stepincubation, namely at 96° C. for 2 minutes, at 50° C. for 1 minute andat 72° C. for 1 minute was repeated to a total of 35 times. The reactionmixture was subjected to electrophoresis with 12.5% polyacrylamide gelto identify the formation of an amplification fragment of 71 bp. Thefragment was recovered from the gel in the same manner as in (2) ofExample 8, and used as a probe.

(2) Southern Hybridization

Restriction endonuclease Xho I (produced by Takara Shuzo, 36 U) wasadded to 10 μg of chromosomal DNA of Dactylosporanaium sp. RH1, and themixture was incubated at 37° C. for 2 hours. DNA was cleaved, andsubjected to electrophoresis with agarose gel using the probe obtainedin (1) of Example 9 and DIG Luminescent Detection Kit produced byBoehringer Mannheim, and Southern hybridization was conducted accordingto the method described in a manual attached to the Kit.

That is, after the completion of the agarose gel electrophoresis, theagarose gel was shaked gently in 0.25 N hydrochloric acid for 20minutes, and then dipped in a mixture of 0.5 M sodium hydroxide and 1.5M sodium chloride for 50 minutes and further in a mixture of 2 M sodiumchloride and 1M tris.HCl (pH 5.0) for 25 minutes. While sucking the gelat 7.5 mmHg by means of a Genopirator Pump AE-6680P produced by Atto Co.and a Genopirator AE-6680C also produced by Atto Co., Hybond-N⁺ Film(produced by Amersham) was blotted with the gel in SSC at aconcentration of 20 times (formulation of SSC at a concentration of 1time—150 mM sodium chloride and 15 mM sodium citrate). After thecompletion of the blotting, the film was dried at 80° C. for 10 minutes,and then crosslinked using FUNA-UV-LINKER FS-800 (produced byFunakoshi). The thus-obtained film was dipped in 10 ml of ahybridization buffer (solution obtained by dissolving 50% v/v formamide,2% blocking reagent, 0.1% w/v N-laurylsarcosine and 0.02% w/v SDS in SSCat a concentration of 5 times) of a DIG Luminescent Detection Kit at 42°C. for 1 hour, and then dipped in a probe solution [obtained by adding 3μl of the probe obtained in (1) of Example 9 to 200 μl of ahybridization buffer, treating the mixture at 95° C. for 2 minutes, andthen adding the hybridization buffer to adjust the total amount to 1.5ml] overnight at 42° C. The thus-obtained film was further washed twicewith 25 ml of 0.1% SDS containing SSC at a concentration of 2 times atroom temperature for 5 minutes each, and then washed twice with 25 ml of0.1% SDS containing SSC at a concentration of 0.1 time at 68° C. for 15minutes each.

The thus-washed film was treated with a washing buffer [Buffer 1 (0.1 Mmaleic acid, 0.15 M sodium chloride, pH 7.5) containing 0.3% w/vTween-20] at room temperature for 1 to 5 minutes, with 50 ml of Buffer 2(Buffer 1 containing 1% blocking reagent) at room temperature for 30minutes, with Buffer 2 containing 10 ml of 1 μm anti-digoxigenin-AP Fabat room temperature for 30 minutes, twice with 50 ml of Buffer 2 at roomtemperature for 30 minutes each, with 10 ml of Buffer 3 (a buffercontaining 0.1 M tris.HCl, 0.1 M sodium chloride and 50 mM magnesiumchloride, pH 9.5) at room temperature for from 2 to 5 minutes, and with5 ml of Buffer 3 containing 50 μl of Lumigen PPD at room temperature for5 minutes in this order. Subsequently, water was removed from the filmquickly over a filter paper, wrapped with Saran Wrap, and then allowedto stand at 37° C. for 15 minutes. The resulting film was exposed atroom temperature for 30 minutes using a Hyperfilm-ECL (produced byAmersham).

It was found that the DNA fragment which had hybridized strongly withthe probe was present at a position of approximately 5.5 kb.

(3) Fractionation of Chromosomal DNA

Restriction endonuclease Xho I (produced by Takara Shuzo Co., Ltd., 360U) was added to 100 μg of chromosomal DNA of Dactylosporanaium sp. RH1,and the mixture was incubated at 37° C. for 2 hours. After DNA wascleaved, an equal amount of a mixture of TE saturated phenol-chloroformwas added thereto, and mixed. After the mixture was centrifuged, theupper layer was taken, and mixed gently with 2.2 volumes of coldethanol. The mixture was centrifuged at 10,000 rpm for 10 minutes. Afterthe supernatant was discarded, the precipitate was washed twice with 70%cold ethanol to obtain an ethanol precipitate (hereinafter the procedurefor obtaining the ethanol precipitate using the mixture of TE saturatedphenol-chloroform mixture and the cold ethanol referred to as “ethanolprecipitation”). The precipitate was dissolved in 120 μl of TE, and themixture was subjected to agarose gel electrophoresis. After thecompletion of the electrophoresis, a DNA fraction of approximately 5.5kb was extracted from the agarose gel and purified using Prep-A-gene(produced by Biorad Co.) to obtain approximately 7 μg of the Xho Icleaved chromosomal DNA fraction.

(4) Construction of Phage Library

Using an undigested λZAPII Cloning Kit produced by Stratagene, a phagelibrary was formed as follows.

Restriction endonuclease Xho I (produced by Takara Shuzo Co., Ltd., 36U) was added to 5 μg of λZAPII DNA, and the mixture was incubated at 37°C. for 3 hours. After DNA was cleaved, the ethanol precipitate wasobtained by ethanol precipitation. After the ethanol precipitate wasdissolved in 35 μl of TE, the solution was dephosphorylated usingAlkaline Phosphatase (Calf Intestine) produced by Takara Shuzo Co., Ltd.according to the method described in a manual attached thereto. Afterthe completion of the dephosphorylation, the ethanol precipitate wasobtained by the ethanol precipitation. The thus-obtained XhoI-cleavedλZAPII DNA (0.36 μg) was reacted with 0.35 μg of Xho I-cleavedchromosomal DNA obtained in (3) of Example 9 at 26° C. for 2.5 hoursusing a ligation kit (TAKARA Ligation Kit produced by Takara Shuzo Co.,Ltd.) to ligate the two. Ethanol was added to the reaction mixture, andthe resulting DNA precipitate was dissolved in 4 μl of TE. The DNA wasfurther packaged in λphage particles using a Gigapack II Gold PackagingExtract produced by Stratagene.

Meanwhile, E. coli XL1-Blue MRF′ strain (produced by Stratagene) wasinoculated in 3 ml of LB medium (solution obtained by dissolving 10 g ofbactotryptone, 5 g of bactoyeast extract and 5 g of NaCl in 1 liter ofdistilled water and sterilized at 120° C. for 20 minutes) containing0.2% (w/v) maltose and 10 mM magnesium sulfate, and cultivated at 30° C.for 16 hours. After the completion of the cultivation, the cells werecollected by centrifugation, and suspended in 10 mM of a sterilizedmagnesium sulfate solution such that the absorbance at 600 nm wasapproximately 0.5.

Two-hundred microliters of the above-obtained cell solution was mixedwith 10 μl of a packaging solution, and the mixed solution was thenincubated at 37° C. for 15 minutes. To the mixed solution were added 50μl of a solution (250 mg X-Gal/ml-dimethylformamide) containing 3 ml ofLB soft agar medium (obtained by adding an agar to LB medium such thatthe amount of the agar was 0.6%), 15 μl of a 0.5 M IPTG aqueous solutionand 50 μl of a solution (250 mg X-Gal/ml.dimethylformamide) containingX-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside). The mixture was puton LB agar medium (obtained by adding an agar to LB medium such that theamount of the agar was 1.8%), and cultivated overnight at 37° C.

Approximately 5,000 colorless plagues were obtained and used as a phagelibrary.

(5) Selection of an Intended Clone

The plaque having the intended clone was selected from theabove-mentioned phage library as follows.

The plaques appearing on the LB agar medium were shifted onto a nylonfilm (Nytran produced by Schleicher & Schuell) washed with SSC at aconcentration of 5 times. Subsequently, the film was allowed to stand ona filter paper immersed with 0.5 M sodium hydroxide and 1.5 M sodiumchloride. Further, the film was allowed to stand on a filter paperimmersed with 1.5 M sodium chloride and 0.5 M tris.HCl (pH 8.0) twicefor 2 minutes each and on a filter paper immersed with SSC at aconcentration of 2 times for 2 minutes each. Subsequently, the resultingfilm was dried at 80° C. for 30 minutes. The dried film was washed with0.1% SDS containing SSC at a concentration of 2 times and then with SSCat a concentration of 2 times, and air-dried.

The detection was conducted using the DIG probe obtained in (1) ofExample 9 and a DIG Luminescent Detection Kit produced by BoehringerMannheim according to the method described in (1) of Example 9.Consequently, one positive plaque having the intended clone wasdetected.

(6) Identification of a Clone

A portion of approximately 1 cm² around the positive plaque was cut out.One milliliter of SM (a medium containing 5.8 g/l sodium chloride, 2 g/lmagnesium chloride, 0.01% gelatin, and 50 mM tris.HCl, pH 7.5) and 20 μlof chloroform were added thereto. The mixture was stirred thoroughly,and then centrifuged. The thus-obtained supernatant was used as a phageextract.

A sense strand DNA primer indicated in Sequence No. 7 corresponding toNucleotides Nos. 13 to 32 of the nucleotide sequence described inSequence No. 6 and an anti-sense strand DNA primer indicated in SequenceNo. 8 corresponding to Nucleotides Nos. 53 to 71 of the nucleotidesequence indicated in Sequence No. 6 (provided that the nucleotidecorresponding to Nucleotide No. 66 indicated in Sequence No. 6 was G)were synthesized by means of 380A•DNA Synthesizer manufactured byApplied Biosystems.

Using 5 μl of the phage extract, the sense strand DNA primer indicatedin Sequence No. 7 and the anti-sense strand DNA primer indicated inSequence No. 8, the PCR was conducted according to the method describedin (3) of Example 8 to obtain a DNA fragment of 59 bp. The DNA fragmentwas analyzed by electrophoresis with 12.5% polyacrylamide, andidentified as the intended clone.

The procedures described in (4) to (6) of Example 9 were repeated exceptthat the above-obtained phage extract was used instead of the packagingliquid shown in (4) of Example 9 to purify the intended clone.

(7) Formation of a Plasmid by in vivo Excision of the Phage DNA

Formation of a plasmid by in vivo excision of the phage DNA in theextract obtained in (6) of Example 9 was conducted using an undigestedλZAPII Cloning Kit produced by Stratagene according to a methoddescribed in a manual attached thereto is described below.

E. coli XL1-Blue MRF′ strain was inoculated in 3 ml of LB mediumcontaining 0.2% (w/v) maltose and 10 mM magnesium sulfate according to amethod described in (4) of Example 9 and was cultivated at 30° C. for 16hours. After the completion of the cultivation, the culture wascentrifuged, and the obtained cells were suspended in 10 mM magnesiumsulfate solution such that the absorbance at 600 nm was approximately1.0. To 200 μl of the cell solution were added 100 μl of the phageextract obtained in (6) of Example 9 and 1 μl of an ExAssist HelperPhage (produced by Stratagene), and the mixture was incubated at 37° C.for 15 hours. To this reaction mixture was added 3 ml of 2xYT (obtainedby dissolving 10 g sodium chloride, 10 g yeast extract and 16 g ofbactotryptone in 1 liter of distilled water, and sterilized at 120° C.for 20 minutes), and the mixture was shaken at 37° C. for 2 hours. Theresulting solution was heated at 70° C. for 20 minutes, and centrifugedto obtain a supernatant. One microliter of the supernatant was added to200 μl of E. coli SOLR strain cultivated in the same manner as E. coliXL1-Blue MRF′ strain. The mixture was incubated at 37° C. for 15minutes, then spread on LB agar medium containing 50 μg/ml ofampicillin, and cultivated overnight at 37° C. A positive colony wasselected from the colonies grown on the agar medium according to themethod described in (6) of Example 9 except that the colonies were usedinstead of the phage extract.

A plasmid was extracted from the thus-obtained positive colony in ausual manner, and the structure thereof was identified by digestion withrestriction endonucleases. The thus-obtained plasmid pRH71 had astructure in which the Xho I-cleaved DNA fragment having a size ofapproximately 5.5 kb was inserted in the Xho I site of pBluescript SK(−)as shown in FIG. 1.

(8) Determination of Nucleotide Sequence

From the Xho I fragment having a size of approximately 5.5 kb insertedin the above-obtained pRH71, a Sac I-Xho I fragment having a size ofapproximately 2.4 kb (fragment to be cleaved with Xho I-1 and Sac I-1 inFIG. 1) and a Sac I fragment having a size of approximately 2 kb(fragment to be cleaved with Sac I-1 and Sac I-2) were cleaved with therespective restriction endonucleases and thereby obtained, and subclonedat the Sac I-Xho I cleavage site and the Sac I cleavage site ofpBluescript KS(+) to obtain plasmids pYan10 and pYan13 as shown in FIG.1.

Using a deletion kit for kilosequences produced by Takara Shuzo Co.,Ltd., deletion mutant plasmids were constructed from pYanlO according toa method described in a manual attached thereto.

A nucleotide sequence of the Sac I-Xho I fragment having the size ofapproximately 2.4 kb in the deletion plasmid was determined using asequence determination kit (Taq DyeDeoXy™ Terminator Cycle SequencingKit produced by Applied Biosystems).

With respect to pYan13, deletion mutant plasmids were constructed, andthe nucleotide sequence determination was conducted in the same manneras mentioned above to determine the nucleotide sequence of the Sac I-SacI fragment (fragment to be cleaved with Sac I-1 and Sac I-2 in FIG. 1)in the Sac I fragment having the size of approximately 2 kb.

The nucleotide sequence of the Sac I-Xho I fragment (fragment to becleaved with Xho I-1 and Sac I-2 in FIG. 1) 2707b is indicated inSequence No. 9.

In the thus-determined nucleotide sequence, the nucleotide sequence(corresponding to Nucleotide Nos. 264 to 1079 in Sequence No. 9)represented by Sequence No. 3, which encodes a protein composed of 272amino acids indicated in Sequence No. 2 was present. This amino acidsequence included the N-terminal amino acid sequence indicated inSequence No. 1 which was determined using purifiedL-proline-4-hydroxylase. Thus, it was identified that the intendedL-proline-4-hydroxylase gene was present in the obtained Xho I fragmenthaving a size of approximately 5.5 kb.

EXAMPLE 10

Construction of an L-Proline-4-Hydroxylase Expression Plasmid

(1) Construction of an Expression Plasmid using trp Promoter(Ptrp)

A sense strand DNA primer indicated in Sequence No. 10 and an anti-sensestrand DNA primer indicated in Sequence No. 11 were synthesized by380A•DNA Synthesizer manufactured by Applied Biosystems. The PCR wasconducted using the synthetic DNA's as the primers and pRH71 as atemplate. The reaction was conducted in the same manner as in Example 8using 20 μl of a reaction mixture containing 0.1 μg of pRH71, 2 μM sensestrand DNA primer and 2 μM anti-sense strand DNA primer. That is, afterincubation at 96° C. for 5 minutes, a three step incubation, namely at96° C. for 2 minutes, at 58° C. for 1 minute and at 75° C. for 1 minutewas repeated for a total of 30 times. The reaction mixture was subjectedto agarose gel electrophoresis. After it was identified that anamplified fragment of 844 bp encoding the structural gene ofL-proline-4-hydroxylase was formed, the amplified fragment was extractedfrom the agarose gel in a usual manner, and recovered using Prep-A-geneproduced by Biorad Co. Both terminals of the DNA fragment of 844 bprecovered were cleaved with Hind III and Bam HI, and an ethanolprecipitate was then obtained by the ethanol precipitation. The ethanolprecipitate was dissolved in 5 μl of TE.

Plasmid pTrS30DNA containing Ptrp was cleaved by Hind III and Bam HI.The L-proline-4-hydroxylase structural gene fragment treated with HindIII and Bam HI was inserted into the cleavage site via the ligation kitproduced by Takara Shuzo Co., Ltd. Using the thus-obtained plasmid, E.coli XL1-Blue MRF′ strain was transformed in a usual manner. Thetransformant was spread on LB agar medium containing 50 μg/ml ofampicillin, and then cultivated overnight at 37° C. The plasmid wasextracted from the colony of the grown transformant in a usual manner,and the structure of the plasmid was identified by digestion with arestriction endonuclease.

As a result, plasmid pTr14 in which the DNA fragment containing thestructural gene of L-proline-4-hydroxylase was inserted in the samedirection as the transcription direction of Ptrp was obtained as shownin FIG. 2.

(2) Construction of an Expression Plasmid Using tac Promotor(Ptac)

An expression plasmid using Ptac was constructed in the same manner asin (1) of Example 10.

A sense strand DNA primer as indicated in Sequence No. 12 and ananti-sense strand DNA primer as indicated in Sequence No. 13 weresynthesized. Using the synthetic DNAs as the primers and pRH71 as atemplate, the PCR was conducted to obtain an amplification fragment of846 bp containing the structural gene of L-proline-4-hydroxylase. Thisfragment was cleaved by Eco RI and Hind III, then inserted into the EcoRI-Hind III cleavage site of plasmid pBTacl containing Ptac (produced byBoehringer Mannheim), and transformed into E. coli XL1-Blue MRF′ stain.

Plasmid pTc4OH in which the DNA fragment containing the structural geneof L-proline-4-hydroxylase was inserted in the same direction as thetranscription direction of Ptac was obtained from the resultingtransformant as shown in FIG. 3.

(3) Construction of an Expression Plasmid Using Ptrpx2

In the same manner as in (1) of Example 10, an amplified fragmentcontaining the structural gene of L-proline-4-hydroxylase was recovered,processed with restriction enzymes and an ethanol precipitate was thenobtained by ethanol precipitation. The ethanol precipitate was dissolvedin 5 μl of TE.

An ATG vector, pTrS32 formed by combining a synthetic linker and plasmidpKYP200, which is composed of a basic plasmid pBR322 together with twopromoters Ptrps connected in series (Ptrpx2), was cleaved with Hind IIIand Bam HI. Hind III-Bam HI fragment containing the structural gene ofL-proline-4-hydroxylase in the above was inserted into the Hind III-BamHI cleavage site of the vector, using a ligation kit (produced by TakaraShuzo Co.).

Using the thus-obtained plasmid, E. coli XL1-Blue MRF′ strain weretransformed in a usual manner. The transformant was spread on LB-agarmedium containing 50 μg/ml of ampicillin and then cultivated thereonovernight at 37° C. The plasmid was extracted from the grown colonies ofthe transformant cells in a usual manner, and the structure of theplasmid was identified by digestion with restriction enzyme. The part ofthe structural gene of L-proline-4-hydroxylase was sequenced todetermine its nucleotide sequence, using a base sequencing kit (TaqDyeDeoxy™ Terminator Cycle Sequencing Kit, produced by AppliedBiosystems Co.), which revealed that the nucleotide sequence of thestructural gene is indicated by Sequence No. 3.

As a results, plasmid pTr2-4OH in which the DNA fragment encoding thestructural gene of L-proline-4-hydroxylase was inserted in the samedirection as the transcription direction of Ptrpx2 was obtained shown inFIG. 4.

A DNA as indicated in Sequence No. 14 and a DNA as indicated in SequenceNo. 15 were synthesized, using 380A-DNA Synthesizer (produced by AppliedBiosystems Co.). These DNAs were so designed that their 3′ terminals of25 bp are complementary to each other. These DNAs each have a nucleotidesequence coding for the N-terminal site of Dactylosporangium sp.RH1-derived L-proline-4-hydroxylase protein, in which the nucleotidesequence has been site-specifically substituted to make it a codon thatis the most suitable in its expression in Escherichia coli.

Using these synthetic DNA's as primers and templates, PCR was conducted.The reaction was conducted, using 20 μl of a reaction mixture comprising0.5 U of Pfu DNA polymerase (produced by STRATAGENE Co.), 2 μl of ×10buffer for Pfu DNA polymerase, 2 μl of DMSO, 1 μl of 2.5 mM dNTP, 2 μMof the synthetic DNA of Sequence No. 14 and 2 μM of the synthetic DNA ofSequence No. 15. The reaction mixture was incubated at 96° C. for 5minutes. Subsequently, a three step incubation, namely at 96° C. for 2minutes, at 50° C. for 1 minute and at 75° C. for 1 minute was repeatedfor a total of 35 times. After the resulting reaction mixture wassubjected to 15% polyacrylamide gel electrophoresis, the formation of anamplified fragment of 107 bp was identified. The amplified fragment wasrecovered from the gel in the same manner as in (2) of Example 8. Theboth terminals of the thus-recovered DNA fragment of 107 bp were cleavedwith Hind III and Sal I, and the thus-processed fragment was recoveredusing MERmaid Kit (produced by Bio. Inc.). The amount of the liquid thusrecovered was 16 μl.

Plasmid pTr2-4OH DNA was cleaved with Bam HI and Pvu II. The reactionmixture was subjected to agarose gel electrophoresis, through which theformation of two fragments was identified. Of these, the longer fragmenthaving the structural gene of L-proline-4-hydroxylase was isolated,using Prep-A-Gene (produced by Biorad Co.), and its terminals wereblunted using a blunting kit (produced by Takara Shuzo Co.) and thencyclized using a ligation kit (produced by Takara Shuzo Co.). With thethus-obtained plasmid, E. coli JM109 strain was transformed in a usualmanner, and the resulting transformant cells were spread on LB-agarmedium containing 50 μg/ml of ampicillin and then cultivated thereonovernight at 37° C. A plasmid was extracted from the grown colonies ofthe transformant cells in a usual manner, and its structure wasidentified through digestion with restriction enzyme. As a result of theabove, obtained was plasmid pTr2-4OHΔ, which is lacking for a part ofthe sequence of pTr2-4OH (see FIG. 5).

Plasmid pTr2-4OHΔ DNA was cleaved with Hind III and Sal I. ThePCR-amplified fragment that had been processed with Hind III and Sal Iin the above was inserted into the Hind III-Sal I cleavage site of theplasmid, using a ligation kit (produced by Takara Shuzo Co.). With thethus-obtained plasmid, cells of E. coli XL1-Blue MRF′ strain weretransformed in a usual manner, and the resulting transformant cells werespread on LB-agar medium containing 50 μg/ml of ampicillin and thencultivated thereon overnight at 37° C. A plasmid was extracted from thegrown colonies of the transformant cells in a usual manner, and itsstructure was identified through digestion with restriction enzyme. Thepart of the plasmid into which the PCR-amplified fragment had beeninserted was sequenced, using a base sequencing kit (Taq DyeDeoxy™Terminator Cycle Sequencing Kit, produced by Applied Biosystems Co.), todetermine its nucleotide sequence, which revealed that the nucleotidesequence is indicated by Sequence No. 16.

As a result of the above, obtained was plasmid pWFH1 containing thestructural gene DNA fragment coding for the amino acid sequence which isentirely the same as the Dactylosporangium sp. RH1-derivedL-proline-4-hydroxylase except that from the 5′-terminal to the Sal Isite of the structural gene is partly different from theDactylosporangium sp. RH1-derived nucleotide sequence, in the samedirection as transcription direction of Ptrpx2 (see FIG. 6).

EXAMPLE 11

Production of L-Proline-4-Hydroxylase by Transformant

E. coli ATCC12435 was transformed with plasmids, pTr14, pTc4OH and pWFH1as obtained in Example 10 to obtain transformants, E. coliATCC12435/pTr14, E. coli ATCC12435/pTc4OH and E. coli ATCC12435/pWFH1,respectively. E. coli ATCC12435/pTr14 and E. coli ATCC12435/pTc4OH wereseparately inoculated each in 3 ml of an LB medium containing 50 μg/mlof ampicillin and cultivated therein overnight at 30° C. with shaking.

E. coli ATCC12435/pWFH1 was inoculated in 50 ml of a Med4 medium [1% ofpolypeptone (produced by Nippon Pharmaceuticals Co.), 0.5% of yeastextract (produced by Difco Co.) and 1% of NaCl] containing 100 μg/ml ofampicillin and cultivated therein for 16 hours at 30° C. The resultingculture was used as a seed culture, which was inoculated in a 5 literjar fermenter filled with 2 liters of a Med6 medium (2% of glucose, 1%of ammonium sulfate, 0.1% of K₂HPO₄, 0.2% of NaCl, 0.05% of MgSO₄,0.0278% of FeSO₄, 0.0015% of CaCl₂, 0.4% of polypeptone), to which wasadded 200 mM of L-proline. The mixture was subjected to the cultivationin the jar fermenter under the condition of 400 rpm and 1 vvm, at 30° C.for 48 to 72 hours. During the incubation, glucose and L-proline weresuitably added to the medium in such a manner that glucose was alwayspresent in the medium and L-proline could be at about 50 mM therein, andthe lowermost limit of the pH of the medium was controlled at 6.5 byadding NH₄OH to the medium.

The thus-obtained cultures were centrifuged respectively to separate thecells.

The L-proline-4-hydroxylase activity of the cells was measured under theconditions mentioned below. If desired, the cells can be frozen andstored at −20° C., and the frozen cells can be thawed and used in themeasurement of the enzymatic activity.

The cells separated as above were added to 250 μl of a reaction mixture[comprising 12 mM L-proline, 24 mM 2-ketoglutaric acid, 4 mM ferroussulfate and 8 mM L-ascorbic acid in 240 mM MES buffer (pH 6.5)] in anamount of 4% (w/v) in terms of the wet cells and reacted at 35° C. for10 minutes. The reaction mixture was heated at 100° C. for 2 minutes tostop the reaction.

After the reaction was stopped, the resulting reaction mixture wascentrifuged, and 100 μl of 0.3M borate buffer (pH 10.7), 4 μl of 10%(v/v) mercaptoethanol and 16 μl of 5% (w/v) o-phthalaldehyde in ethanolwere added to 100 μl of the resulting supernatant and the reactionmixture was kept at 60° C. for 30 seconds. Then, 50 μl of 2% (w/v) NBDin ethanol was added to the reaction mixture and kept at 60° C. for 40minutes. Thirty microliters of 1 N HCl was added to the reaction mixtureto stop the reaction. The resulting reaction mixture was centrifuged andfiltrated through a filter to remove the precipitate therefrom, and theresulting filtrate was analyzed through HPLC by which the producttrans-4-hydroxy-L-proline produced was quantitatively determined.

The HPLC was conducted under the conditions mentioned below.

Mobile Phase: 10 mM citric acid (pH 4.0)/methanol = 3/1 (v/v) Flow Rate:1 ml/min. Column: YMC Pack ODS AQ-312 (produced by YMC Co., 6 × 150 mm).Column Temperature: 50° C. Wavelength for Detection: excited wavelengthof 503 nm emission wavelength of 541 nm.

As is shown in Table 9 below, the transformants producedL-proline-4-hydroxylase by from 210 to 1420 times/cell as much as theDactylosporangium sp. RH1 strain which had been used as the gene source.

TABLE 9 L-proline-4-hydroxylase Activity Produced by Transformants CellRelative Strain Activity¹⁾ Activity²⁾ E. coli ATCC12435/pWFH1 40.00 1428E. coli ATCC12435/pWFH1³⁾ 4.96 177 E. coli ATCC12435/pTr14 10.68 381 E.coli ATCC12435/pTc4OH 5.98 213 E. coli ATCC12435/pTrS30 Not — detected.E. coli ATCC12435/pBTTac1 Not — detected. Dactylosporangium sp. RH1⁴⁾0.028 1 Streptomyces griseoviridis JCM4250⁵⁾ 0.020 0.7 Streptomycesdaghestanicus JCM4365⁵⁾ 0.009 0.3 ¹⁾Cell activity indicates theenzymatic activity per mg of wet cells (U/mg wet cells). One U indicatesthe enzymatic activity of producing 1 nmol of trans-4-hydroxy-L-prolineper minute (nmol/min). ²⁾Relative activity is based on the enzymaticactivity produced by Dactylosporangium sp. RH1 strain of being 1 (one).³⁾The strain was cultivated in the same manner as above but in theabsence of L-proline in the jar fermenter. ⁴⁾described in (2) ofExample 1. ⁵⁾described in (2) of Example 3.

EXAMPLE 12

Construction of an Expression Plasmid for a Fused Protein

(1) Construction of an Expression Plasmid for a Fused Protein with aβ-Galactosidase Protein Fragment

After 2.4 μg of plasmid pBluescript II KS(+) DNA was cleaved withRestriction endonucleases Eco RV and Xba I, an ethanol precipitate wasobtained by the ethanol precipitation. The ethanol precipitate wasdissolved in 5 μl of TE.

After 4 μg of plasmid pRH71 DNA was cleaved with Restrictionendonuclease Sac I, an ethanol precipitate was obtained in the samemanner as mentioned above. After the ethanol precipitate (DNA fragment)was dissolved in 36 μl of TE, both terminals of the DNA fragment wereblunted using a Takara DNA Blunting Kit produced by Takara Shuzo Co.,Ltd. The treated DNA was subjected to agarose gel electrophoresis. A DNAfragment of approximately 2.4 kb was extracted from the gel in a usualmanner, and recovered using a Prep-A-gene produced by Biorad Co. Therecovered DNA was cleaved with Xba I, and an ethanol precipitate wasobtained in the same manner as mentioned above. The ethanol precipitate(DNA fragment) was dissolved in 10 μl of TE.

The thus-obtained DNA fragment was ligated with Eco RV-Xba I cleavedpBluescript IIKS(+) DNA fragment obtained above.

After E. coli XL2-Blue MRF′ strain (produced by Stratagene) wastransformed using the thus-ligated DNA, the transformant was spread onLB agar medium containing 50 μg/ml of ampicillin, 0.2 mM IPTG and 40μg/ml of X-Gal, and cultivated overnight at 37° C.

The plasmid was extracted in a usual manner from the colony grown on themedium, and the structure of the plasmid was identified by digestionwith restriction endonuclease.

Further, the PCR was conducted using the plasmid as a template, DNAindicated in Sequence No. 17 as a sense strand primer and DNA indicatedin Sequence No. 8 as an anti-sense strand primer. Since a DNA fragmentof 50 bp, corresponding to an N-terminal amino acid sequence ofL-proline-4-hydroxylase was formed by the above-mentioned reaction, itwas identified that the structural gene of the intendedL-proline-4-hydroxylase was inserted into the plasmid.

Plasmid pES1-23a in which the structural gene of L-proline-4-hydroxylasewas inserted in the same direction as the transcription direction of lacpromoter (Plac) in the form fused with 34 N-terminal amino acids ofβ-Gal was obtained by the above-mentioned method as shown in FIG. 7. Theamino acid sequence of the fused protein formed is shown in Sequence No.19.

(2) Construction of an Expression Plasmid for a Fused Protein with aMaltose Binding Protein

Using DNA indicated in Sequence No. 18 as a sense strand primer, DNAindicated in Sequence No. 13 as an antisense strand primer and pRH71 asa template, the PCR was conducted in the same manner as in (2) ofExample 8. That is, 20 μl of a reaction mixture containing 0.1 μg ofpRH71, 2 μM of the sense strand DNA primer and 2 μM of the anti-sensestrand DNA primer was incubated at 96° C. for 5 minutes. Subsequently, athree step incubation, namely at 96° C. for 2 minutes, at 58° C. for 1minute and at 75° C. for 1 minute was repeated for a total of 30 times.

After the reaction mixture was subjected to agarose gel electrophoresis,an amplified fragment of 833 bp containing a structural gene ofL-proline-4-hydroxylase was extracted in a usual manner, and the DNAfragment was recovered using a Prep-A-gene produced by Biorad Co. TheDNA fragment of 833 bp recovered was cleaved with Hind III, and anethanol precipitate was then obtained by the ethanol precipitation. Theethanol precipitate was dissolved in 5 μl of TE, and used as thestructural gene fragment of L-proline-4-hydroxylase.

Plasmid pMAL-c2 having only a structural gene of a maltose bindingprotein without a signal sequence (Protein Fusion & Purification Systemproduced by New England Biolabs) was cleaved with Xmn I and Hind IIIwhile regulating by Ptac.

The structural gene fragment of L-proline-4-hydroxylase was insertedinto the Xmn I-Hind III cleavage site of pMAL-c2 using a DNA ligationkit produced by Takara Shuzo Co., Ltd., and transformed E. coli XL2-BlueMRF′ strain in a usual manner. The transformant was spread on an LB agarmedium containing 50 μg/ml of ampicillin, and then cultivated overnightat 37° C. The plasmid was extracted from the thus-obtained colony in ausual manner, and the structure of the plasmid was identified bydigestion with restriction endonuclease.

Plasmid pMc4OH in which the DNA fragment encoding the structural gene ofL-proline-4-hydroxylase was inserted in the form fused with thestructural gene of the maltose binding protein while regulating by Ptacwas obtained by the above-mentioned method as shown in FIG. 8. The aminoacid sequence of the fused protein formed is shown in Sequence No. 20.

EXAMPLE 13

Production of L-Proline-4-Hydroxylase by a Transformant Containing aFused Protein Expression Plasmid

E. coli DH1 was transformed using the plasmids pES1-23a and pMc4OHobtained in Example 12. The obtained transformant was cultivated in thesame manner as in Example 11 except that a medium containing 0.1 mM IPTGwas used, and the productivity of L-proline-4-hydroxylase of thetransformant was measured in the same manner as in Example 11.

As shown in Table 10, the transformant produced L-proline-4-hydroxylasein an amount of from 29 to 298 times per cell in comparison toDactylosporangium sp. RH1 strain used as a gene source.

TABLE 10 Activities of L-proline-4-hydroxylase Produced by TransformantsCell Relative Strain Activity¹⁾ Activity³⁾ E. coli DH1/pES1-23a 0.80 29E. coli DH1/pMc40H 8.35 298 E. coli DH1/pBluescript IIKS (+) Not —detected E. coli DH1/pMAL-c2 Not — detected Dactylosporangium sp. RH1²⁾0.028 1 ¹⁾The cell activity is shown in terms of enzymatic activity permg of wet cells (U/mg-wet cells). One U indicates the enzymatic activityof producing 1 nmol of trans-4-hydroxy-L-proline per minute (nmol/min).²⁾described in (2) of Example 1. ³⁾The relative activity is shown bydefining the enzymatic activity given from Dactylosporangium sp. RH1strain as 1.

EXAMPLE 14

Construction of Strain Losing Proline Decomposition Activity

A gene putA that participates in the proline decomposition in E. coliATCC12435 was broken according to the method mentioned below toconstruct a strain losing proline decomposition activity.

Cells of a stock strain E. coli ME8395 [F⁻:pyrD34, trp-45, his-68,thyA25, thi deoR33, galK35, xyl-7, mtl-2, malA1, rpsL118, λ^(R) (λ)⁻,appA1, putA::Tn5 (Mu⁺)] available from the National Institute ofGenetics were inoculated in LB medium containing 35 μg/ml of kanamycin,and cultivated overnight.

Then 100 μl of a solution of P1 phage was added to and mixed with 100 μlof the resulting culture, and left as it was for 5 minutes.

The resulting mixture was mixed with 3 ml of LB-soft agar mediumcontaining 10 mM of CaCl₂, then layered over an LB-agar mediumcontaining 10 mM of CaCl₂, and cultivated at 37° C. for 7 hours.

After the cultivation, the phage lysate thus formed on the surface ofthe agar medium was collected in 2 ml of an LB medium containing 10 mMof CaCl₂.

To the liquid thus collected, 0.5 ml of chloroform was added, mixedtherewith, using a Vortex mixer, and then centrifuged at 3000 rpm for 15minutes. The resulting supernatant was used as a P1 phage lysate.

Then 50 μl of the P1 phage lysate liquid was mixed with 100 μl of aculture of E. coli ATCC12435 that had been cultivated in an LB mediumcontaining 10 mM of CaCl₂, and then was kept standing at 37° C. for 20minutes.

The resulting liquid mixture was mixed with 3 ml of F-top-citrate(containing 8.5 g/l of NaCl, 100 mM of disodiumcitrate, and 0.7% ofagar), applied onto an LB-agar medium containing 35 μg/ml of kanamycin,and cultivated at 37° C. for one day.

The kanamycin-resistant cells thus grown through the cultivation weresuspended in 0.85% NaCl, then spread onto a Pro-TTC plate (comprising 7g/liter of K₂HPO₄, 3 g/liter of KH₂PO4, 0.1 g/liter of MgSO₄, 2 g/literof proteose peptone, 0.025 g/l of 2,3,5-triphenyltetrazolium chloride, 2g/l of L-proline and 15 g/l of agar, pH 7.2), and cultivated at 37° C.for 1 to 2 days.

The strain that had produced white colonies on the Pro-TTC plate throughthe cultivation was selected as a strain losing the activity ofdecomposing and assimilating proline. Thus was obtained a strain losingproline decomposition activity, E. coli WT1.

The strain WT1 has been deposited with National Institute of Bioscienceand Human-Technology, Agency of Industrial Science and Technology inJapan as of Aug. 7, 1996 under FERM BP-5618 in terms of the BudapestTreaty.

EXAMPLE 15

Construction of Plasmid Expressing Proline Biosynthetic Genes DroB74 andproA

A plasmid pPF1 was constructed according to the method mentioned below,using the plasmid expressing a mutant gene proB74 (this was mutated froman E. coli-derived gene proB which codes for γ-glutamyl kinase, to bedesensitized to the feedback inhibition with proline) and an E.coli-derived gene proA which codes for γ-glutamyl phosphate reductase.

A plasmid pPRO-1 containing E. coli-derived genes proA and proB [thiswas obtained from a strain E. coli K83 (FERM BP-2807)] was cleaved withEcoRV and then subjected to agarose gel electrophoresis, from which wasobtained a DNA fragment of about 1 kb containing a part of the geneproB, using a Prep-A-gene DNA Purification System (produced by BIO-RADCo.).

The DNA fragment was ligated with pUC19 (produced by Takara Shuzo Co.)that had been cleaved with SmaI, to obtain a plasmid pBAB51 (see FIG.9).

The gene proB existing in the plasmid was mutated into a known, mutantgene proB74 as desensitized to the feedback inhibition with proline [seeA. M. Dandekarand S. L. Uratsu, J. Bacteriol. 170, 5943 (1988)],according to the method mentioned below.

An oligonucleotide A1 as indicated in Sequence No. 21 and anoligonucleotide A2 as indicated in Sequence No. 22 were synthesized,using a DNA synthesizer, 380A-Model (produced by Applied BiosystemsCo.).

A partial sequence of the mutant gene proB74 that had been mutated fromproB was amplified through PCR, using a pair of primers, oligonucleotideA1 and M13 primer M3 (produced by Takara Shuzo Co.—Catalog No. 3831) andusing pBAB51 as a template.

The PCR was conducted, using 20 μl of a reaction mixture comprising 0.1μg of pBAB51, 2 μM of oligonucleotide A1, 2 μM of M13 primer M3, 1 U ofTaq DNA polymerase (produced by Takara Shuzo Co.), 1.6 μl of dNTPmixture (produced by Takara Shuzo Co.—Catalog No. 4030) and 2 μl of anadditive buffer. A three step incubation, namely at 94° C. for 30seconds, at 52° C. for 30 seconds and at 72° C. for 1 minute wasrepeated for a total of 30 times. Finally, the thus-incubated system wasfurther incubated at 72° C. for 5 minutes.

In the same manner as above, a partial sequence of the mutant gene proBwas amplified through PCR, using a pair of primers, oligonucleotide A2and M13 primer RV (produced by Takara Shuzo Co.—Catalog No. 3830A) andusing pBAB51 as a template.

These two DNAs that had been amplified through such PCR were separatelysubjected to agarose gel electrophoresis and then purified usingPrep-A-gene DNA Purification System (produced by BIO-RAD Co.).

In the same manner as above except using a mixture of the two pure DNAfragments as a template along with M13 primer M3 and M13 primer RV asprimers, a DNA fragment of about 1 kb containing a nucleotide sequenceof proB74 was obtained through PCR and purification.

The DNA fragment was cleaved with EcoO65I and SacII to obtain anEcoO65I-SacII cleaved fragment.

This fragment was ligated with a DNA fragment (of about 6.8 kbp) asobtained from pPRO-1 through digestion with EcoO65I and SacII toconstruct a plasmidpPRO74, which is different frompPRO-1 in that theproB gene of pPRO-1 has been substituted with the de-sensitized proB74gene (see FIG. 10).

An oligonucleotide p1 of Sequence No. 23 and an oligonucleotide p2 ofSequence No. 24 were synthesized, using a DNA synthesizer, 380A•Model(produced by Applied Biosystems Co.).

proB74 and proA were amplified through PCR, using these p1 and p2 asprimers and using pPRO74 as a template.

The PCR was conducted, using 20 μl of a reaction mixture comprising 0.1μg of pPRO74, 2 μM of μl, 2 μM of p2, 1 U of Takara EX Taq (produced byTakara Shuzo Co.—Code RR001Q)) and 1.6 μl of dNTP mixture (produced byTakara Shuzo Co.—Catalog No. 4030). A three step incubation, namely at94° C. for 1 minute, at 42° C. for 2 minute and at 73° C. for 3 minutewas repeated for a total of 30 times.

The resulting reaction mixture was subjected to agarose gelelectrophoresis, through which was extracted an amplified fragment of2370 bp containing proB74 and proA in a usual manner, and the DNAfragment was collected using GENECLEAN II KIT (produced by BIO 101,Inc.). The thus-collected DNA fragment of 2370 bp was cleaved withHindIII and BamHI, and then an ethanol precipitate was obtained byethanol precipitation. The ethanol precipitate was dissolved in 5 μl TEand used as a fragment having proB74 and proA.

The fragment having proB74 and proA was ligated with a DNA fragment asobtained by digesting a plasmid pSTV29 (produced by Takara Shuzo Co.)with HindIII and BamHI, using a DNA ligation kit (produced by TakaraShuzo Co.) to construct a plasmid having proB74 and proA.

E. coli JM109 strain was transformed with the plasmid obtained above ina usual manner, and the resulting transformant cells were spread on anLB-agar medium comprising 30 μg/ml of chloramphenicol and 0.1 mM ofIPTG, 40 μg/ml of X-Gal, and cultivated at 37° C. overnight.

A plasmid was extracted in a usual manner from the strain that hadproduced white colonies through the cultivation, and the structure ofthe plasmid was identified by digestion with restriction enzyme.

After the process mentioned above, obtained was a plasmid pPF1 having ade-sensitized gene that codes for a fused protein composed of γ-glutamylkinase with N-terminal, eight amino acid residues (lacZ.Nterm) of theα-fragment of β-galactosidase as fused to its N-terminal, and having agene proA under the control of Plac (see FIG. 11).

The nucleotide sequence and the amino acid sequence of the structuralgene (lacZ.Nterm-proB74) of the fused protein are indicated by SequenceNo. 25.

EXAMPLE 16

Construction of Plasmid Expressing L-Proline-4-Hydroxylase Gene andProline Biosynthesis Genes proB74 and proA

A plasmid pWFP1 was constructed according to the method mentioned below,the plasmid carrying capable of expressing all of a Dactylosporangiumsp. RH1-derived L-proline-4-hydroxylase gene and genes proB74 and proAsuch as those as produced in Example 15.

The structural gene of L-proline-4-hydroxylase was amplified throughPCR, using pWFH1 that had been produced in (3) of Example 10, as atemplate. For the reaction, used was 20 μl of a reaction mixturecomprising 0.1 μg of pWFH1, 0.5 U of Pfu DNA polymerase (produced bySTRATAGENE Co.), 2 μl of ×10 buffer for Pfu DNA polymerase (produced bySTRATAGENE Co.), 2 μl of DMSO, 1 μl of 2.5 mM dNTP, 2 μM of thesynthetic DNA as indicated in Sequence No. 26 and 2 μM of the syntheticDNA as indicated in Sequence No. 27. Prior to the subsequent cyclereaction, the reaction mixture was pre-incubated at 96° C. for 5minutes. A three step incubation, namely at 96° C. for 2 minutes, at 58°C. for 1 minutes and at 75° C. for 3 minute was repeated for a total of30 times. After thus reacted, the reaction mixture was subjected toagarose gel electrophoresis, through which was extracted an amplifiedfragment of about 800 pb having an L-proline-4-hydroxylase gene in ausual manner. The DNA fragment was collected, using GENECLEAN II KIT(produced by BIO 101, Inc.). The thus-collected DNA fragment was cleavedwith HindIII and EcoRI and then subjected to agarose gelelectrophoresis, through which was collected a DNA fragment usingGENECLEAN II KIT (produced by BIO 101, Inc.). The thus-collected,L-proline-4-hydroxylase gene fragment was ligated with a DNA fragment asobtained through digestion of a plasmid pBluescriptII KS(+) (produced bySTRATAGENE Co.) with HindIII and EcoRI, using a DNA ligation kit(produced by Takara Shuzo Co.), to thereby construct a plasmid pBII-4OHhaving an L-proline-4-hydroxylase fragment as inserted thereinto (seeFIG. 12).

Genes proB74 and proA were amplified through PCR, using the pPRO74 thathad been produced in Example 15, as a template. For the reaction, usedwas 20 μl of a reaction mixture comprising 0.1 μg of pPRO74, 1 U ofTakara Ex Taq (produced by Takara Shuzo Co.—Code RR001Q), 2 μl of ×10buffer for Takara Ex Taq (produced by Takara Shuzo Co.), 1.6 μl of 2.5mM DNTP, 2 μM of the synthetic DNA of Sequence No. 28 and 2 μM of thesynthetic DNA of Sequence No. 29. A three step incubation, namely at 94°C. for 1 minute, at 42° C. for 2 minutes and at 75° C. for 3 minute wasrepeated for a total of 30 times. After thus reacted, the reactionmixture was subjected to agarose gel electrophoresis, through which wasextracted an amplified fragment of about 2.3 kbp having genes proB74 andproA in a usual manner. The DNA fragment was collected, using GENECLEANII KIT (produced by BIO 101, Inc.). The thus-collected DNA fragment wascleaved with BamHI and EcoRI, then treated with phenol/chloroform, andprecipitated with ethanol, and the DNA fragment was collected. Thethus-collected DNA fragment having genes proB74 and proA was ligatedwith a DNA fragment as obtained through digestion of the plasmidpBII-4OH with HindIII and EcoRI, using a DNA ligation kit (produced byTakara Shuzo Co.), to thereby construct a plasmid pBII-4OHBA havingL-proline-4-hydroxylase gene and genes proB74 and proA (see FIG. 13).

The plasmid pBII-4OHBA was cleaved with HindIII and BamHI, and thensubjected to agarose gel electrophoresis, through which was collected aDNA fragment of about 3.16 kbp having L-proline-4-hydroxylase gene andgenes proB74 and proA. On the other hand, pWFH1 that had been producedin (3) of Example 10 was cleaved with HindIII and BamHI, and thensubjected to agarose gel electrophoresis, through which was collected aDNA fragment of about 2.6 kbp not having L-proline-4-hydroxylase genebut having a replication-starting point. These two DNA fragments thusobtained were ligated, using a DNA ligation kit (produced by TakaraShuzo Co.), to thereby construct a plasmid pWFP1 capable of expressingL-proline-4-hydroxylase, proB74 protein and proA protein under thecontrol of a tryptophan tandem promoter (see FIG. 14).

EXAMPLE 17

Production of Trans-4-Hydroxy-L-Proline by Transformant:

(1) Production of Trans-4-hydroxy-L-proline by Transformant E. coliATCC12435/pTr14

The transformant cells of E. coli ATCC12435/pTr14 as obtained in Example11 were inoculated in 3 ml of an LB medium containing 100 μg/ml ofampicillin and cultivated therein at 30° C. for 16 hours with shaking.The resulting culture was centrifuged, and the amount oftrans-4-hydroxy-L-proline in the supernatant thus separated wasquantitatively determined.

As a result, 381 μM (50.0 mg/liter) of trans-4-hydroxy-L-proline wereformed in the supernatant of the culture of E. coli ATCC12435/pTr14.

On the other hand, trans-4-hydroxy-L-proline was not detected in thesupernatant of the culture of E. coli ATCC12435 which had been used asthe host.

(2) Production of Trans-4-Hydroxy-L-Proline by Transformant E. coliATCC12435/pWFH1:

Transformant cells of E. coli ATCC12435/pWFH1 were inoculated in 50 mlof a Med4 medium containing 100 μg/ml of ampicillin and 2% of glucose,and cultivated therein at 30° C. for 16 hours with shaking. The culturewas used as a seed culture. The seed culture was inoculated in a 5 literjar fermenter filled with 2 liters of a Med6 medium containing 0.8% ofpeptone in place of polypeptone and the cells were cultivated in thefermenter under the condition of 400 rpm and 1 vvm, at 33° C.

During the cultivation, glucose was suitably added to the medium so asnot to make glucose absent in the medium, and the lowermost limit of thepH of the medium was controlled at 6.5 by adding NH₄OH to the medium.

The culture was centrifuged, and the amount of trans-4-hydroxy-L-prolinein the supernatant separated was quantitatively determined. Fifty twohours after the start of the incubation, 10.7 mM (1.4 g/liter) oftrans-4-hydroxy-L-proline was produced and accumulated in thesupernatant of the culture of E. coli ATCC12435/pWFH1.

On the other hand, free trans-4-hydroxy-L-proline was not detected inthe supernatant of the culture of E. coli ATCC12435 used as the host.

(3) Production of Trans-4-Hydroxy-L-Proline by Transformant HavingProline Biosynthesis Gene-Expressing Plasmid

The strain E. coli WT1 as prepared in Example 11 was transformed withthe plasmid pPF1 as constructed in Example 15, to obtain a transformantE. coli WT1/pPF1.

The strain WT1 as prepared in Example 11 was transformed with theproline 4-hydroxylase-expressing plasmid pWFH1 as constructed in (3) ofExample 10, to obtain a transformant E. coli WT1/pWFH1.

Competent cells of the transformant E. coli WT1/pWFH1 were preparedaccording to a calcium chloride method, into which was introduced theplasmid pPF1 that had been produced in Example 15. Thus was obtained atransformant E. coli WT1/pWFH1/pPF1 having the two plasmids through theselection of the colonies as growing on an LB medium containing 30 μg/mlof chloramphenicol and 50 μg/ml of ampicillin.

Strains of WT1, WT1/pPF1, WT1/pWFH1 and WT1/pWFH1/pPF1 were separatelycultivated in LB medium each comprising 37.5 μg/ml of kanamycin, 100μg/ml of ampicillin, 30 μg/ml of chloramphenicol, or both 100 μg/ml ofampicillin and 30 μg/ml of chloramphenicol, respectively, at 37° C. for16 hours.

Then 100 μl of each culture was inoculated in a test tube (ø 20×200 mm)filled with 10 ml of a Med7 medium (comprising 2% of glucose, 1% ofammonium sulfate, 0.1% of K₂HPO₄, 0.2% of NaCl, 0.05% of MgSO₄, 0.0278%of FeSO₄, 0.0015% of CaCl₂ and 0.8% of peptone)containing 2% (w/v) ofcalcium carbonate, and cultivated at 30° C. for 24 hours.

The amount of L-proline and that of trans-4-hydroxy-L-proline in theculture supernatant are shown in Table 11.

TABLE 11 Strain L-proline Trans-4-hydroxy- (g/l) (g/l) L-proline E. coliWT1 0.05 0.00 E. coli WT1/pPF1 1.20 0.00 E. coli WT1/pWFH1 0.00 0.07 E.coli WT1/pWFH1/pPF1 0.20 0.67

It is known from the above data that the transformants having theproline biosynthesis gene-expressing plasmid pPF1 produced a largeramount of L-proline than the others and that the transformant havingboth the L-proline 4-hydroxylase-expressing plasmid pWFHl and theproline biosynthesis gene-expressing plasmid pPF1 produced a largeramount of trans-4-hydroxy-L-proline than the transformant having onlythe L-proline 4-hydroxylase-expressing plasmid pWFH1.

(4) Production of Trans-4-Hydroxy-L-Proline by Transformant E. coliWT1/pWFH1/pPF1

The transformant of WT1/pWFH1/pPF1 was inoculated in 50 ml of a Med4Gmedium [comprising 2% of glucose, 1% of polypeptone (produced by NipponSeiyaku KK), 0.5% of yeast extract (produced by Difco Co.), 1% of NaCl,2% of calcium carbonate, pH 7.0] containing 100 μg/ml of ampicillin and100 μg/ml of chloramphenicol, and cultivated therein at 30° C. for 16hours with shaking.

The resulting culture was used as a seed culture and inoculated in a5-liter jar fermenter filled with 2 liters of a Med7 medium, to whichwas added 100 μg/ml of ampicillin and 30 μg/ml of chloramphenicol. Thetransformant in the culture was cultivated under the condition of 400rpm and 1 vvm, at 30° C.

At 8 hours after the start of cultivation, IPTG was added to the mediumso as to make the IPTG concentration of 0.2 mM.

At 24 hours after the start of cultivation, ampicillin andchloramphenicol were added to the medium so as to make ampicillinconcentration of 100 μg/ml and the chloramphenicol concentration of 30μg/ml.

During the cultivation, glucose was suitably added to the medium so asto make the glucose concentration of about 1%, and the lowermost limitof the pH of the medium was controlled at 6.5 by adding NH₄OH to themedium. Five hours after the start of the cultivation, the concentrationof the dissolved oxygen in the culture was controlled to be {fraction(1/15)} of that at the start of the cultivation by varying the stirringspeed within the range between 250 rpm and 700 rpm.

The culture was centrifuged, and the amount of trans-4-hydroxy-L-prolinein the supernatant was quantitatively determined. Ninety nine hoursafter the start of the cultivation, 156 mM (20.5 g/l) oftrans-4-hydroxy-L-proline was produced and accumulated in thesupernatant of the culture of E. coli WT1/pWFH1/pPF1.

(5) Production of Trans-4-Hydroxy-L-Proline by Transformant HavingPlasmid Expressing L-Proline 4-Hydroxylase Gene and Proline BiosynthesisGene

The strain E. coli WT1 as prepared in Example 15 was transformed withthe plasmid pWFP1 as constructed in Example 16, to obtain a transformantE. coli WT1/pWFP1.

The transformant of E. coli WT1/pWFP1 was cultivated in an LB mediumcontaining 100 μg/ml of ampicillin, at 37° C. for 16 hours. Then 100 μlof the culture was inoculated in a test tube (Ø 20×200 mm) filled with10 ml of a Med7 medium containing 2% (w/v) of calcium carbonate, andcultivated therein at 30° C. for 24 hours.

The amount of L-proline in the supernatant of the culture was 0.56g/liter, and that of trans-4-hydroxy-L-proline in the same was 2.4g/liter.

(6) Production of Trans-4-Hydroxy-L-Proline by Transformant E. coliWT1/pWFP1

The transformant of WT1/pWFP1 was inoculated in 50 ml of aMed4G mediumcontaining 100 μg/ml of ampicillin, and cultivated therein at 30° C. for16 hours with shaking.

The resulting culture was used as a seed culture and inoculated in a5-liter jar fermenter filled with 2 liters of a Med7 medium, to whichwas added 100 μg/ml of ampicillin. The transformant in the culture wascultivated under the condition of 400 rpm and 1 vvm, at 30° C.

At 24 hours after the start of cultivation, ampicillin was added to themedium so as to make the ampicillin concentration of 100 μg/ml.

During the cultivation, glucose was suitably added to the medium so asto make constantly the glucose concentration of about 1%, and thelowermost limit of the pH of the medium was controlled at 6.5 by addingNH₄OH to the medium. Five hours after the start of the cultivation, theconcentration of the dissolved oxygen in the culture was controlled tobe {fraction (1/15)} of that at the start of the cultivation by varyingthe stirring speed within the range between 250 rpm and 700 rpm.

The culture was centrifuged, and the amount of trans-4-hydroxy-L-prolinein the supernatant was quantitatively determined. Ninety nine hoursafter the start of the cultivation, 191 mM (25.0 g/l) oftrans-4-hydroxy-L-proline was produced and accumulated in thesupernatant of the culture of E. coli WT1/pWFP1.

(7) Production of Trans-4-Hydroxy-L-Proline by Transformant E. coliATCC12435/pWFH1

Transformant cells of E. coli ATCC12435/pWFH1 were inoculated in 50 mlof a Med4 medium containing 100 μg/ml of ampicillin and cultivatedtherein at 30° C. for 16 hours with shaking. The culture was used as aseed culture. The seed culture was inoculated in a 5 liter jar fermenterfilled with 2 liters of a Med6 medium. 200 mM of L-proline was added tothe medium. The cells were cultivated in the fermenter under thecondition of 400 rpm and 1 vvm, at 30° C.

During the incubation, glucose and L-proline were suitably added to themedium in such a manner that glucose was always present in the mediumand that L-proline could be at about 50 mM therein, and the lowermostlimit of the pH of the medium was controlled at 6.5 by adding NH₄OH tothe medium.

The culture was centrifuged, and the amount of trans-4-hydroxy-L-prolinein the supernatant separated was quantitatively determined. Seventy twohours after the start of the incubation, 185 mM (24 g/liter) oftrans-4-hydroxy-L-proline was produced and accumulated in thesupernatant of the culture of E. coli ATCC12435/pWFH1.

On the other hand, free trans-4-hydroxy-L-proline was not detected inthe supernatant of the culture of E. coli ATCC12435 used as the host.

(8) Production of Trans-4-Hydroxy-L-Proline by Transformant E. coliATCC12435/pMc4OH

Transformant cells of E. coli ATCC12435/pMc4OH were inoculated in 50 mlof a Med4 medium containing 100 μg/ml of ampicillin and cultivatedtherein at 30° C. for 16 hours with shaking. The culture was used as aseed culture. The seed culture was inoculated in a 5 liter jar fermenterfilled with 2 liters of a Med6 medium. 200 mM of L-proline was added tothe medium. The cells were cultivated in the fermenter under thecondition of 400 rpm and 1 vvm, at 30° C.

During the incubation, glucose and L-proline were suitably added to themedium in such a manner that glucose was always present in the mediumand that L-proline could be at about 50 mM therein, and the lowermostlimit of the pH of the medium was controlled at 6.5 by adding NH₄OH tothe medium.

The culture was centrifuged, and the amount of trans-4-hydroxy-L-prolinein the supernatant separated was quantitatively determined. Seventy twohours after the start of the incubation, 85.4 mM (11.2 g/liter) oftrans-4-hydroxy-L-proline was produced and accumulated in thesupernatant of the culture of E. coli ATCC12435/pMc4OH.

On the other hand, free trans-4-hydroxy-L-proline was not detected inthe supernatant of the culture of E. coli ATCC12435 which had been usedas the host.

EXAMPLE 18

Conversion of L-proline into Trans-4-Hydroxy-L-Proline with TransformantCells

Transformant cells of E. coli ATCC12435/pTr14 were inoculated in 10 mlof an LB medium containing 50 μg/ml of ampicillin and cultivated thereinovernight at 30 c with shaking. The culture was centrifuged to collectthe cells. If desired, the cells were frozen and stored at −20° C. andthawed before use.

The cells were added to 250 μl of a reaction mixture (comprising 20 mML-proline, 24 mM2-ketoglutaric acid, 4 mM ferrous sulfate and 8 mML-ascorbic acid in 240 mM MES buffer, pH 6.5) at 10% (w/v) in terms ofthe wet cells, and reacted at 35° C. for 60 minutes. The amount oftrans-4-hydroxy-L-proline as formed in the reaction mixture wasquantitatively determined. In the mixture, 11.5 mM (1.5 g/liter) oftrans-4-hydroxy-L-proline was produced.

                   #             SEQUENCE LISTING(1) GENERAL INFORMATION:    (iii) NUMBER OF SEQUENCES: 29(2) INFORMATION FOR SEQ ID NO:1:      (i) SEQUENCE CHARACTERISTICS:          (A) LENGTH: 27 amino  #acids           (B) TYPE: amino acid          (C) STRANDEDNESS: single           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: peptide     (vi) ORIGINAL SOURCE:          (A) ORGANISM: Dactylospora #ngium sp.          (B) STRAIN: RH1     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:Met Leu Thr Pro Thr Glu Leu Lys Gln Tyr Ar #g Glu Ala Gly Tyr Leu  1               5  #                 10  #                 15Leu Ile Glu Asp Gly Leu Gly Pro Arg Glu Va #l              20     #             25 (2) INFORMATION FOR SEQ ID NO:2:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 272 amino #acids           (B) TYPE: amino acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: protein    (vi) ORIGINAL SOURCE:           (A) ORGANISM: Dactylospora#ngium sp.           (B) STRAIN: RH1    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:Met Leu Thr Pro Thr Glu Leu Lys Gln Tyr Ar #g Glu Ala Gly Tyr Leu  1               5  #                 10  #                 15Leu Ile Glu Asp Gly Leu Gly Pro Arg Glu Va #l Asp Cys Leu Arg Arg             20      #             25      #             30Ala Ala Ala Ala Leu Tyr Ala Gln Asp Ser Pr #o Asp Arg Thr Leu Glu         35          #         40          #         45Lys Asp Gly Arg Thr Val Arg Ala Val His Gl #y Cys His Arg Arg Asp     50              #     55              #     60Pro Val Cys Arg Asp Leu Val Arg His Pro Ar #g Leu Leu Gly Pro Ala 65                  # 70                  # 75                  # 80Met Gln Ile Leu Ser Gly Asp Val Tyr Val Hi #s Gln Phe Lys Ile Asn                 85  #                 90  #                 95Ala Lys Ala Pro Met Thr Gly Asp Val Trp Pr #o Trp His Gln Asp Tyr            100       #           105       #           110Ile Phe Trp Ala Arg Glu Asp Gly Met Asp Ar #g Pro His Val Val Asn        115           #       120           #       125Val Ala Val Leu Leu Asp Glu Ala Thr His Le #u Asn Gly Pro Leu Leu    130               #   135               #   140Phe Val Pro Gly Thr His Glu Leu Gly Leu Il #e Asp Val Glu Arg Arg145                 1 #50                 1 #55                 1 #60Ala Pro Ala Gly Asp Gly Asp Ala Gln Trp Le #u Pro Gln Leu Ser Ala                165   #               170   #               175Asp Leu Asp Tyr Ala Ile Asp Ala Asp Leu Le #u Ala Arg Leu Thr Ala            180       #           185       #           190Gly Arg Gly Ile Glu Ser Ala Thr Gly Pro Al #a Gly Ser Ile Leu Leu        195           #       200           #       205Phe Asp Ser Arg Ile Val His Gly Ser Gly Th #r Asn Met Ser Pro His    210               #   215               #   220Pro Arg Gly Val Val Leu Val Thr Tyr Asn Ar #g Thr Asp Asn Ala Leu225                 2 #30                 2 #35                 2 #40Pro Ala Gln Ala Ala Pro Arg Pro Glu Phe Le #u Ala Ala Arg Asp Ala                245   #               250   #               255Thr Pro Leu Val Pro Leu Pro Ala Gly Phe Al #a Leu Ala Gln Pro Val            260       #           265       #           270(2) INFORMATION FOR SEQ ID NO:3:      (i) SEQUENCE CHARACTERISTICS:          (A) LENGTH: 816 base  #pairs           (B) TYPE: nucleic acid          (C) STRANDEDNESS: double           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: genomic DNA     (vi) ORIGINAL SOURCE:          (A) ORGANISM: Dactylospora #ngium sp.          (B) STRAIN: RH1     (ix) FEATURE:          (C) IDENTIFICATION METHOD: # by experiment    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:ATGCTGACCC CGACGGAGCT CAAGCAGTAC CGCGAGGCGG GCTATCTGCT CA#TCGAGGAC     60GGCCTCGGCC CGCGGGAGGT CGACTGCCTG CGCCGGGCGG CGGCGGCCCT CT#ACGCGCAG    120GACTCGCCGG ACCGCACGCT GGAGAAGGAC GGCCGCACCG TGCGCGCGGT CC#ACGGCTGC    180CACCGGCGCG ACCCGGTCTG CCGCGACCTG GTCCGCCACC CGCGCCTGCT GG#GCCCGGCG    240ATGCAGATCC TGTCCGGCGA CGTGTACGTC CACCAGTTCA AGATCAACGC GA#AGGCCCCG    300ATGACCGGCG ATGTCTGGCC GTGGCACCAG GACTACATCT TCTGGGCCCG AG#AGGACGGC    360ATGGACCGTC CGCACGTGGT CAACGTCGCG GTCCTGCTCG ACGAGGCCAC CC#ACCTCAAC    420GGGCCGCTGT TGTTCGTGCC GGGCACCCAC GAGCTGGGCC TCATCGACGT GG#AGCGCCGC    480GCGCCGGCCG GCGACGGCGA CGCGCAGTGG CTGCCGCAGC TCAGCGCCGA CC#TCGACTAC    540GCCATCGACG CCGACCTGCT GGCCCGGCTG ACGGCCGGGC GGGGCATCGA GT#CGGCCACC    600GGCCCGGCGG GCTCGATCCT GCTGTTCGAC TCCCGGATCG TGCACGGCTC GG#GCACGAAC    660ATGTCGCCGC ACCCGCGCGG CGTCGTCCTG GTCACCTACA ACCGCACCGA CA#ACGCCCTG    720CCGGCGCAGG CCGCTCCGCG CCCGGAGTTC CTGGCCGCCC GCGACGCCAC CC#CGCTGGTG    780 CCGCTGCCCG CGGGCTTCGC GCTGGCCCAG CCCGTC      #                   #      816 (2) INFORMATION FOR SEQ ID NO:4:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 17 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:ATGCTSACSC CNACNGA              #                   #                  #   17 (2) INFORMATION FOR SEQ ID NO:5:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 17 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:GGSCCSAGNC CRTCYTC              #                   #                  #   17 (2) INFORMATION FOR SEQ ID NO:6:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 71 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: double          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:ATG CTG ACG CCG ACG GAG CTC AAG CAG TAC CG#C GAG GCG GGC TAT CTG       48Met Leu Thr Pro Thr Glu Leu Lys Gln Tyr Ar #g Glu Ala Gly Tyr Leu  1               5  #                 10  #                 15CTC ATC GAG GAC GGT CTG GGC CC       #                  #                71 Leu Ile Glu Asp Gly Leu Gly              20(2) INFORMATION FOR SEQ ID NO:7:      (i) SEQUENCE CHARACTERISTICS:          (A) LENGTH: 20 base  #pairs           (B) TYPE: nucleic acid          (C) STRANDEDNESS: single           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:ACGGAGCTCA AGCAGTACCG             #                  #                   # 20 (2) INFORMATION FOR SEQ ID NO:8:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 19 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:GGGCCGAGAC CGTCCTCGA              #                  #                   # 19 (2) INFORMATION FOR SEQ ID NO:9:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 2707 base #pairs           (B) TYPE: nucleic acid          (C) STRANDEDNESS: double           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: genomic DNA     (vi) ORIGINAL SOURCE:          (A) ORGANISM: Dactylospora #ngium sp.          (B) STRAIN: RH1     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:GAGCTCTACC GGCGAACGCG CNCNCGGTGG CCGAATACGA NCCGGCGCCC CA#CGATGTNC     60GGGCCACCCT CGTGCAGNCG GCCGAGCAGG ACGCCGGGCT ACGGGCGGCG NC#GGTCGAGN    120CGTGGACCCG CGCCTGCGGG GCGCCCCCGN CGGTGCATGT GCTGCCGGGC GG#GCACTTCT    180CGCTCTGCGC CGGCCGCACG TCGAGCGGCT GGCCCGGCTC CTGCCCGGCC TG#TAGGCGAC    240CTAACCCACC GTGAGGAGCG CTCATGCTGA CCCCGACGGA GCTCAAGCAG TA#CCGCGAGG    300CGGGCTATCT GCTCATCGAG GACGGCCTCG GCCCGCGGGA GGTCGACTGC CT#GCGCCGGG    360CGGCGGCGGC CCTCTACGCG CAGGACTCGC CGGACCGCAC GCTGGAGAAG GA#CGGCCGCA    420CCGTGCGCGC GGTCCACGGC TGCCACCGGC GCGACCCGGT CTGCCGCGAC CT#GGTCCGCC    480ACCCGCGCCT GCTGGGCCCG GCGATGCAGA TCCTGTCCGG CGACGTGTAC GT#CCACCAGT    540TCAAGATCAA CGCGAAGGCC CCGATGACCG GCGATGTCTG GCCGTGGCAC CA#GGACTACA    600TCTTCTGGGC CCGAGAGGAC GGCATGGACC GTCCGCACGT GGTCAACGTC GC#GGTCCTGC    660TCGACGAGGC CACCCACCTC AACGGGCCGC TGTTGTTCGT GCCGGGCACC CA#CGAGCTGG    720GCCTCATCGA CGTGGAGCGC CGCGCGCCGG CCGGCGACGG CGACGCGCAG TG#GCTGCCGC    780AGCTCAGCGC CGACCTCGAC TACGCCATCG ACGCCGACCT GCTGGCCCGG CT#GACGGCCG    840GGCGGGGCAT CGAGTCGGCC ACCGGCCCGG CGGGCTCGAT CCTGCTGTTC GA#CTCCCGGA    900TCGTGCACGG CTCGGGCACG AACATGTCGC CGCACCCGCG CGGCGTCGTC CT#GGTCACCT    960ACAACCGCAC CGACAACGCC CTGCCGGCGC AGGCCGCTCC GCGCCCGGAG TT#CCTGGCCG   1020CCCGCGACGC CACCCCGCTG GTGCCGCTGC CCGCGGGCTT CGCGCTGGCC CA#GCCCGTCT   1080AGGCTGCCGC AGGCGGCGCA CGGCCCACCT CAGCGCAGGC CGAGCAGCCG CC#CCACGCCG   1140GCGGCGAAGC GGATCAGGCC GCGCAGGCCG AGCGGCGGGC GAGGCGAGCA TT#GTCGGGCT   1200GCCCAGTCGT CGTGTCGTGG GTGACAGCCC GTGGCGGCTC TTCTGACGGC CC#GCGACGGA   1260TCACGGTCAT GTTTGCCGAT GGGACGTCAC GGTCGTGTGC CCGGACGGTC GA#AAATCACC   1320AGAATGGTGC TGATGGCCTG TCGCGGGGTG TCGGTGGTGC GGTCGCCAGC AT#CCCTCGGC   1380CGCGCCGGGG CCGGTGCGTC TCACCAGGCC GTGCGGGCGT TGACGGCCGA GA#CGGCGGAC   1440CGGAAGGCGG CCACCGGTTC GCCGAGATAG CACCACGGGA ACTCGGTGAC CA#ACTCGCCG   1500ATGGCCAGAA ACTGCATCGC CGCCGCCTCG TCGTCGCCGG CCGCCAGAAA CG#CGACCGCG   1560AACGCGTTGG CGTCCAGGGC CCAGTCCCGG CGCCGCACAT AGCGGCGGTG CC#GGACCGAC   1620TCGCGGGCCG CGTCGTTGAG CGACTCCCGC ACCGCCGCCG AGCGGATGTA GT#CACGGCTA   1680GGCGCGCCAC CGAGGTCCAG CCAGTGTTCA AGGTGCGCCA GGGCGACGAG CG#TGCCAAGA   1740CGGCTGCCCT CGCCTGCGTC CCGCGCGGCC CCCTCGGCGA ACGCGCGCAT CC#GCTCCGGC   1800GAGCCGCCCC ACTTCCGGCA GAGGTTCTGC AGCATCGCGG TGTGGGCGCG GT#AGTTGTCC   1860GGGTCATGCG CGACCGCCGC ATCGAACCGG CGCCGCTGCT CGTCCGCACT CA#GACCCAGG   1920CCACGGGCGA CGGTGATCAG GCCAGTCCAG GCCGTGACAT TGGCCGGCTC CC#GGCGTACC   1980ACCTCCTGCA GGCAGTACTC GGCGAGTTCC AGCCGCTGCC GGAACAGCAC CC#ACGCTCAG   2040GCGGGACGTA CGCGGCAGGA AGCCCGGTGC GAGCCTCCCA GGCCCACGCG AT#CGCCCGGT   2100GACCGCGCAC GAGCAGCGCC AGGGGATCGT CCGGCCCGTG CTCGATTACA TG#CGCACAGC   2160ACAGTGCTCG GTGCCGGGGA CCTGGGCCGC GACCGAGACC AGGAAGTCGA GA#TCCTCTCT   2220TGTGCCGCTC GGCGGCCAGN ATGGGCCGCG CGGNAAGCCA GTCTCCGGCG GC#CAACGCTG   2280CCCACAGCCA CCGGGCGTCG GCATCACCGA GCGTCGGGTC GAAGGCGCGC GC#CACGCGCC   2340CTGCGGACCG CCGGAACAGG GGCATGCGCG CATCCTCCAG CCGATGCGCC GA#TCAGCCGG   2400CGCGGCAAGA TCGTACGCCC GGACCGCGAG GTCGGGAGGT CCACGGGCGG TC#CCCACTGG   2460GCGACGACTG TCAGNTGCTA CGCTGGCCCG GTGGCCGAGA TCACCGGGGC GT#TCGAGATC   2520CATGTAACCG TCGAGGCGCA CCACGGCACG GACCTCGCCC GGTTCGCCGA GA#AGCACGAC   2580GTCAAGTTCC TGCACATCGT CCTGGACCGC GGCCGGTTTC CGTCCCAGCC GA#TCTCACGC   2640TGCCGATGCA CGGCACCCTC GCTCAGGCAC GGAAGACGGC GCCACGTGGC GG#GAGCGGCT   2700 ACTCGAG                  #                  #                   #        2707 (2) INFORMATION FOR SEQ ID NO:10:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 37 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:GTGAGGAAAG CTTATGCTGA CCCCGACGGA GCTCAAG       #                  #      37 (2) INFORMATION FOR SEQ ID NO:11:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 36 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:GCCTGCGGGA TCCTAGACGG GCTGGGCCAG CGCGAA       #                  #       36 (2) INFORMATION FOR SEQ ID NO:12:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 37 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:GTGAGGAGAA TTCATGCTGA CCCCGACGGA GCTCAAG       #                  #      37 (2) INFORMATION FOR SEQ ID NO:13:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 38 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:CCGCCTGAAG CTTCCTAGAC GGGCTGGGCC AGCGCGAA       #                  #     38 (2) INFORMATION FOR SEQ ID NO:14:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 64 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:TGAGGAAAGC TTATGCTGAC CCCGACCGAA CTGAAACAGT ATCGTGAAGC  #              50 GGGCTATCTG CTGA               #                  #                   #     64 (2) INFORMATION FOR SEQ ID NO:15:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 66 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:CCGGAATTCG TCGACTTCAC GCGGGCCCAG GCCATCTTCA ATCAGCAGAT  #              50 AGCCCGCTTC ACGATA              #                  #                   #    66 (2) INFORMATION FOR SEQ ID NO:16:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 816 base #pairs           (B) TYPE: nucleic acid          (C) STRANDEDNESS: double           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:ATG CTG ACC CCG ACC GAA CTG AAA CAG TAT CG#T GAA GCG GGC TAT CTG       48Met Leu Thr Pro Thr Glu Leu Lys Gln Tyr Ar #g Glu Ala Gly Tyr Leu  1               5  #                 10  #                 15CTG ATT GAA GAT GGC CTG GGC CCG CGT GAA GT#C GAC TGC CTG CGC CGG       96Leu Ile Glu Asp Gly Leu Gly Pro Arg Glu Va #l Asp Cys Leu Arg Arg             20      #             25      #             30GCG GCG GCG GCC CTC TAC GCG CAG GAC TCG CC#G GAC CGC ACG CTG GAG      144Ala Ala Ala Ala Leu Tyr Ala Gln Asp Ser Pr #o Asp Arg Thr Leu Glu         35          #         40          #         45AAG GAC GGC CGC ACC GTG CGC GCG GTC CAC GG#C TGC CAC CGG CGC GAC      192Lys Asp Gly Arg Thr Val Arg Ala Val His Gl #y Cys His Arg Arg Asp     50              #     55              #     60CCG GTC TGC CGC GAC CTG GTC CGC CAC CCG CG#C CTG CTG GGC CCG GCG      240Pro Val Cys Arg Asp Leu Val Arg His Pro Ar #g Leu Leu Gly Pro Ala 65                  # 70                  # 75                  # 80ATG CAG ATC CTG TCC GGC GAC GTG TAC GTC CA#C CAG TTC AAG ATC AAC      288Met Gln Ile Leu Ser Gly Asp Val Tyr Val Hi #s Gln Phe Lys Ile Asn                 85  #                 90  #                 95GCG AAG GCC CCG ATG ACC GGC GAT GTC TGG CC#G TGG CAC CAG GAC TAC      336Ala Lys Ala Pro Met Thr Gly Asp Val Trp Pr #o Trp His Gln Asp Tyr            100       #           105       #           110ATC TTC TGG GCC CGA GAG GAC GGC ATG GAC CG#T CCG CAC GTG GTC AAC      384Ile Phe Trp Ala Arg Glu Asp Gly Met Asp Ar #g Pro His Val Val Asn        115           #       120           #       125GTC GCG GTC CTG CTC GAC GAG GCC ACC CAC CT#C AAC GGG CCG CTG TTG      432Val Ala Val Leu Leu Asp Glu Ala Thr His Le #u Asn Gly Pro Leu Leu    130               #   135               #   140TTC GTG CCG GGC ACC CAC GAG CTG GGC CTC AT#C GAC GTG GAG CGC CGC      480Phe Val Pro Gly Thr His Glu Leu Gly Leu Il #e Asp Val Glu Arg Arg145                 1 #50                 1 #55                 1 #60GCG CCG GCC GGC GAC GGC GAC GCG CAG TGG CT#G CCG CAG CTC AGC GCC      528Ala Pro Ala Gly Asp Gly Asp Ala Gln Trp Le #u Pro Gln Leu Ser Ala                165   #               170   #               175GAC CTC GAC TAC GCC ATC GAC GCC GAC CTG CT#G GCC CGG CTG ACG GCC      576Asp Leu Asp Tyr Ala Ile Asp Ala Asp Leu Le #u Ala Arg Leu Thr Ala            180       #           185       #           190GGG CGG GGC ATC GAG TCG GCC ACC GGC CCG GC#G GGC TCG ATC CTG CTG      624Gly Arg Gly Ile Glu Ser Ala Thr Gly Pro Al #a Gly Ser Ile Leu Leu        195           #       200           #       205TTC GAC TCC CGG ATC GTG CAC GGC TCG GGC AC#G AAC ATG TCG CCG CAC      672Phe Asp Ser Arg Ile Val His Gly Ser Gly Th #r Asn Met Ser Pro His    210               #   215               #   220CCG CGC GGC GTC GTC CTG GTC ACC TAC AAC CG#C ACC GAC AAC GCC CTG      720Pro Arg Gly Val Val Leu Val Thr Tyr Asn Ar #g Thr Asp Asn Ala Leu225                 2 #30                 2 #35                 2 #40CCG GCG CAG GCC GCT CCG CGC CCG GAG TTC CT#G GCC GCC CGC GAC GCC      768Pro Ala Gln Ala Ala Pro Arg Pro Glu Phe Le #u Ala Ala Arg Asp Ala                245   #               250   #               255ACC CCG CTG GTG CCG CTG CCC GCG GGC TTC GC#G CTG GCC CAG CCC GTC      816Thr Pro Leu Val Pro Leu Pro Ala Gly Phe Al #a Leu Ala Gln Pro Val            260       #           265       #           270(2) INFORMATION FOR SEQ ID NO:17:      (i) SEQUENCE CHARACTERISTICS:          (A) LENGTH: 20 base  #pairs           (B) TYPE: nucleic acid          (C) STRANDEDNESS: single           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:AAGCAGTACC GCGAGGCGGG             #                  #                   # 20 (2) INFORMATION FOR SEQ ID NO:18:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 21 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:ATGCTGACCC CGACGGAGCT C            #                  #                   #21 (2) INFORMATION FOR SEQ ID NO:19:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 299 amino #acids           (B) TYPE: amino acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: protein    (vi) ORIGINAL SOURCE:           (A) ORGANISM: Dactylospora#ngium sp.           (B) STRAIN: RH1     (ix) FEATURE:          (A) NAME/KEY: peptide           (B) LOCATION: 35 to  #299          (C) IDENTIFICATION METHOD: # by similarity with known sequence               or to  #an established consensus    (vi) ORIGINAL SOURCE:           (A) ORGANISM: Escherichia  #coli   (vii) IMMEDIATE SOURCE: pBluescriptIIKS+     (ix) FEATURE:          (A) NAME/KEY: peptide           (B) LOCATION: 1 to 3 #4          (C) IDENTIFICATION METHOD: # by similarity with known sequence               or to  #an established consensus    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:Met Thr Met Ile Thr Pro Ser Ala Gln Leu Th #r Leu Thr Lys Gly Asn  1               5  #                 10  #                 15Lys Ser Trp Val Pro Gly Pro Pro Ser Arg Se #r Thr Val Ser Ile Ser             20      #             25      #             30Leu Ile Lys Gln Tyr Arg Glu Ala Gly Tyr Le #u Leu Ile Glu Asp Gly         35          #         40          #         45Leu Gly Pro Arg Glu Val Asp Cys Leu Arg Ar #g Ala Ala Ala Ala Leu     50              #     55              #     60Tyr Ala Gln Asp Ser Pro Asp Arg Thr Leu Gl #u Lys Asp Gly Arg Thr 65                  # 70                  # 75                  # 80Val Arg Ala Val His Gly Cys His Arg Arg As #p Pro Val Cys Arg Asp                 85  #                 90  #                 95Leu Val Arg His Pro Arg Leu Leu Gly Pro Al #a Met Gln Ile Leu Ser            100       #           105       #           110Gly Asp Val Tyr Val His Gln Phe Lys Ile As #n Ala Lys Ala Pro Met        115           #       120           #       125Thr Gly Asp Val Trp Pro Trp His Gln Asp Ty #r Ile Phe Trp Ala Arg    130               #   135               #   140Glu Asp Gly Met Asp Arg Pro His Val Val As #n Val Ala Val Leu Leu145                 1 #50                 1 #55                 1 #60Asp Glu Ala Thr His Leu Asn Gly Pro Leu Le #u Phe Val Pro Gly Thr                165   #               170   #               175His Glu Leu Gly Leu Ile Asp Val Glu Arg Ar #g Ala Pro Ala Gly Asp            180       #           185       #           190Gly Asp Ala Gln Trp Leu Pro Gln Leu Ser Al #a Asp Leu Asp Tyr Ala        195           #       200           #       205Ile Asp Ala Asp Leu Leu Ala Arg Leu Thr Al #a Gly Arg Gly Ile Glu    210               #   215               #   220Ser Ala Thr Gly Pro Ala Gly Ser Ile Leu Le #u Phe Asp Ser Arg Ile225                 2 #30                 2 #35                 2 #40Val His Gly Ser Gly Thr Asn Met Ser Pro Hi #s Pro Arg Gly Val Val                245   #               250   #               255Leu Val Thr Tyr Asn Arg Thr Asp Asn Ala Le #u Pro Ala Gln Ala Ala            260       #           265       #           270Pro Arg Pro Glu Phe Leu Ala Ala Arg Asp Al #a Thr Pro Leu Val Pro        275           #       280           #       285Leu Pro Ala Gly Phe Ala Leu Ala Gln Pro Va #l     290              #   295 (2) INFORMATION FOR SEQ ID NO:20:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 659 amino #acids           (B) TYPE: amino acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: protein    (vi) ORIGINAL SOURCE:           (A) ORGANISM: Dactylospora#ngium sp.           (B) STRAIN: RH1     (ix) FEATURE:          (A) NAME/KEY: peptide           (B) LOCATION: 389 to  #659          (C) IDENTIFICATION METHOD: # by experiment    (vi) ORIGINAL SOURCE:           (A) ORGANISM: Escherichia  #coli   (vii) IMMEDIATE SOURCE: pMAL-c2     (ix) FEATURE:          (A) NAME/KEY: peptide           (B) LOCATION: 1 to 3 #87          (C) IDENTIFICATION METHOD: # by similarity with known sequence               or to  #an established consensus    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:Met Lys Ile Glu Glu Gly Lys Leu Val Ile Tr #p Ile Asn Gly Asp Lys  1               5  #                 10  #                 15Gly Tyr Asn Gly Leu Ala Glu Val Gly Lys Ly #s Phe Glu Lys Asp Thr             20      #             25      #             30Gly Ile Lys Val Thr Val Glu His Pro Asp Ly #s Leu Glu Glu Lys Phe         35          #         40          #         45Pro Gln Val Ala Ala Thr Gly Asp Gly Pro As #p Ile Ile Phe Trp Ala     50              #     55              #     60His Asp Arg Phe Gly Gly Tyr Ala Gln Ser Gl #y Leu Leu Ala Glu Ile 65                  # 70                  # 75                  # 80Thr Pro Asp Lys Ala Phe Gln Asp Lys Leu Ty #r Pro Phe Thr Trp Asp                 85  #                 90  #                 95Ala Val Arg Tyr Asn Gly Lys Leu Ile Ala Ty #r Pro Ile Ala Val Glu            100       #           105       #           110Ala Leu Ser Leu Ile Tyr Asn Lys Asp Leu Le #u Pro Asn Pro Pro Lys        115           #       120           #       125Thr Trp Glu Glu Ile Pro Ala Leu Asp Lys Gl #u Leu Lys Ala Lys Gly    130               #   135               #   140Lys Ser Ala Leu Met Phe Asn Leu Gln Glu Pr #o Tyr Phe Thr Trp Pro145                 1 #50                 1 #55                 1 #60Leu Ile Ala Ala Asp Gly Gly Tyr Ala Phe Ly #s Tyr Glu Asn Gly Lys                165   #               170   #               175Tyr Asp Ile Lys Asp Val Gly Val Asp Asn Al #a Gly Ala Lys Ala Gly            180       #           185       #           190Leu Thr Phe Leu Val Asp Leu Ile Lys Asn Ly #s His Met Asn Ala Asp        195           #       200           #       205Thr Asp Tyr Ser Ile Ala Glu Ala Ala Phe As #n Lys Gly Glu Thr Ala    210               #   215               #   220Met Thr Ile Asn Gly Pro Trp Ala Trp Ser As #n Ile Asp Thr Ser Lys225                 2 #30                 2 #35                 2 #40Val Asn Tyr Gly Val Thr Val Leu Pro Thr Ph #e Lys Gly Gln Pro Ser                245   #               250   #               255Lys Pro Phe Val Gly Val Leu Ser Ala Gly Il #e Asn Ala Ala Ser Pro            260       #           265       #           270Asn Lys Glu Leu Ala Lys Glu Phe Leu Glu As #n Tyr Leu Leu Thr Asp        275           #       280           #       285Glu Gly Leu Glu Ala Val Asn Lys Asp Lys Pr #o Leu Gly Ala Val Ala    290               #   295               #   300Leu Lys Ser Tyr Glu Glu Glu Leu Ala Lys As #p Pro Arg Ile Ala Ala305                 3 #10                 3 #15                 3 #20Thr Met Glu Asn Ala Gln Lys Gly Glu Ile Me #t Pro Asn Ile Pro Gln                325   #               330   #               335Met Ser Ala Phe Trp Tyr Ala Val Arg Thr Al #a Val Ile Asn Ala Ala            340       #           345       #           350Ser Gly Arg Gln Thr Val Asp Glu Ala Leu Ly #s Asp Ala Gln Thr Asn        355           #       360           #       365Ser Ser Ser Asn Asn Asn Asn Asn Asn Asn As #n Asn Asn Leu Gly Ile    370               #   375               #   380Glu Gly Arg Met Leu Thr Pro Thr Glu Leu Ly #s Gln Tyr Arg Glu Ala385                 3 #90                 3 #95                 4 #00Gly Tyr Leu Leu Ile Glu Asp Gly Leu Gly Pr #o Arg Glu Val Asp Cys                405   #               410   #               415Leu Arg Arg Ala Ala Ala Ala Leu Tyr Ala Gl #n Asp Ser Pro Asp Arg            420       #           425       #           430Thr Leu Glu Lys Asp Gly Arg Thr Val Arg Al #a Val His Gly Cys His        435           #       440           #       445Arg Arg Asp Pro Val Cys Arg Asp Leu Val Ar #g His Pro Arg Leu Leu    450               #   455               #   460Gly Pro Ala Met Gln Ile Leu Ser Gly Asp Va #l Tyr Val His Gln Phe465                 4 #70                 4 #75                 4 #80Lys Ile Asn Ala Lys Ala Pro Met Thr Gly As #p Val Trp Pro Trp His                485   #               490   #               495Gln Asp Tyr Ile Phe Trp Ala Arg Glu Asp Gl #y Met Asp Arg Pro His            500       #           505       #           510Val Val Asn Val Ala Val Leu Leu Asp Glu Al #a Thr His Leu Asn Gly        515           #       520           #       525Pro Leu Leu Phe Val Pro Gly Thr His Glu Le #u Gly Leu Ile Asp Val    530               #   535               #   540Glu Arg Arg Ala Pro Ala Gly Asp Gly Asp Al #a Gln Trp Leu Pro Gln545                 5 #50                 5 #55                 5 #60Leu Ser Ala Asp Leu Asp Tyr Ala Ile Asp Al #a Asp Leu Leu Ala Arg                565   #               570   #               575Leu Thr Ala Gly Arg Gly Ile Glu Ser Ala Th #r Gly Pro Ala Gly Ser            580       #           585       #           590Ile Leu Leu Phe Asp Ser Arg Ile Val His Gl #y Ser Gly Thr Asn Met        595           #       600           #       605Ser Pro His Pro Arg Gly Val Val Leu Val Th #r Tyr Asn Arg Thr Asp    610               #   615               #   620Asn Ala Leu Pro Ala Gln Ala Ala Pro Arg Pr #o Glu Phe Leu Ala Ala625                 6 #30                 6 #35                 6 #40Arg Asp Ala Thr Pro Leu Val Pro Leu Pro Al #a Gly Phe Ala Leu Ala                645   #               650   #               655Gln Pro Val (2) INFORMATION FOR SEQ ID NO:21:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 22 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:GACCCGTGCT AATATGGAAG AC            #                  #                 22 (2) INFORMATION FOR SEQ ID NO:22:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 22 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:GTCTTCCATA TTAGCACGGG TC            #                  #                 22 (2) INFORMATION FOR SEQ ID NO:23:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 33 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:GGCAAAGCTT CATGAGTGAC AGCCAGACGC TGG        #                  #         33 (2) INFORMATION FOR SEQ ID NO:24:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 33 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:TTTGCAGGAT CCGGTTTTAT TTACGCACGA ATG        #                  #         33 (2) INFORMATION FOR SEQ ID NO:25:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 1125 base #pairs           (B) TYPE: nucleic acid          (C) STRANDEDNESS: double           (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:ATG ACC ATG ATT ACG CCA AGC TTC ATG AGT GA#C AGC CAG ACG CTG GTG       48Met Thr Met Ile Thr Pro Ser Phe Met Ser As #p Ser Gln Thr Leu Val  1               5  #                 10  #                 15GTA AAA CTC GGC ACC AGT GTG CTA ACA GGC GG#A TCG CGC CGT CTG AAC       96Val Lys Leu Gly Thr Ser Val Leu Thr Gly Gl #y Ser Arg Arg Leu Asn             20      #             25      #             30CGT GCC CAT ATC GTT GAA CTT GTT CGC CAG TG#C GCG CAG TTA CAT GCC      144Arg Ala His Ile Val Glu Leu Val Arg Gln Cy #s Ala Gln Leu His Ala         35          #         40          #         45GCC GGG CAT CGG ATT GTT ATT GTG ACG TCG GG#C GCG ATC GCC GCC GGA      192Ala Gly His Arg Ile Val Ile Val Thr Ser Gl #y Ala Ile Ala Ala Gly     50              #     55              #     60CGT GAG CAC CTG GGT TAC CCG GAA CTG CCA GC#G ACC ATC GCC TCG AAA      240Arg Glu His Leu Gly Tyr Pro Glu Leu Pro Al #a Thr Ile Ala Ser Lys 65                  # 70                  # 75                  # 80CAA CTG CTG GCG GCG GTA GGG CAG AGT CGA CT#G ATT CAA CTG TGG GAA      288Gln Leu Leu Ala Ala Val Gly Gln Ser Arg Le #u Ile Gln Leu Trp Glu                   #85                   #90                   #95CAG CTG TTT TCG ATT TAT GGC ATT CAC GTC GG#G CAA ATG CTG CTG ACC      336Gln Leu Phe Ser Ile Tyr Gly Ile His Val Gl #y Gln Met Leu Leu Thr            100       #           105       #           110CGT GCT AAT ATG GAA GAC CGT GAA CGC TTC CT#G AAC GCC CGC GAC ACC      384Arg Ala Asn Met Glu Asp Arg Glu Arg Phe Le #u Asn Ala Arg Asp Thr         115          #        120          #        125CTG CGA GCG TTG CTC GAT AAC AAT ATC GTT CC#G GTA ATC AAT GAG AAC      432Leu Arg Ala Leu Leu Asp Asn Asn Ile Val Pr #o Val Ile Asn Glu Asn    130               #   135               #   140GAT GCT GTC GCT ACG GCA GCG ATT AAG GTC GG#C GAT AAC GAT AAC CTT      480Asp Ala Val Ala Thr Ala Ala Ile Lys Val Gl #y Asp Asn Asp Asn Leu145                 1 #50                 1 #55                 1 #60TCT GCG CTG GCG GCG ATT CTT GCG GGT GCC GA#T AAA CTG TTG CTG CTG      528Ser Ala Leu Ala Ala Ile Leu Ala Gly Ala As #p Lys Leu Leu Leu Leu                165   #               170   #               175ACC GAT CAA AAA GGT TTG TAT ACC GCT GAC CC#G CGC AGC AAT CCG CAG      576Thr Asp Gln Lys Gly Leu Tyr Thr Ala Asp Pr #o Arg Ser Asn Pro Gln            180       #           185       #           190GCA GAA CTG ATT AAA GAT GTT TAC GGC ATT GA#T GAC GCA CTG CGC GCG      624Ala Glu Leu Ile Lys Asp Val Tyr Gly Ile As #p Asp Ala Leu Arg Ala        195           #       200           #       205ATT GCC GGT GAC AGC GTT TCA GGC CTC GGA AC#T GGC GGC ATG AGT ACC      672Ile Ala Gly Asp Ser Val Ser Gly Leu Gly Th #r Gly Gly Met Ser Thr    210               #   215               #   220AAA TTG CAG GCC GCT GAC GTG GCT TGC CGT GC#G GGT ATC GAC ACC ATT      720Lys Leu Gln Ala Ala Asp Val Ala Cys Arg Al #a Gly Ile Asp Thr Ile225                 2 #30                 2 #35                 2 #40ATT GCC GCG GGC AGC AAG CCG GGC GTT ATT GG#T GAT GTG ATG GAA GGC      768Ile Ala Ala Gly Ser Lys Pro Gly Val Ile Gl #y Asp Val Met Glu Gly                245   #               250   #               255ATT TCC GTC GGT ACG CTG TTC CAT GCC CAG GC#G ACT CCG CTT GAA AAC      816Ile Ser Val Gly Thr Leu Phe His Ala Gln Al #a Thr Pro Leu Glu Asn            260       #           265       #           270CGT AAA CGC TGG ATT TTC GGT GCG CCG CCG GC#G GGT GAA ATC ACG GTA      864Arg Lys Arg Trp Ile Phe Gly Ala Pro Pro Al #a Gly Glu Ile Thr Val        275           #       280           #       285GAT GAA GGG GCA ACT GCC GCC ATT CTG GAA CG#C GGC AGC TCC CTG TTG      912Asp Glu Gly Ala Thr Ala Ala Ile Leu Glu Ar #g Gly Ser Ser Leu Leu    290               #   295               #   300CCG AAA GGC ATT AAA AGC GTG ACT GGC AAT TT#C TCG CGT GGT GAA GTC      960Pro Lys Gly Ile Lys Ser Val Thr Gly Asn Ph #e Ser Arg Gly Glu Val305                 3 #10                 3 #15                 3 #20ATC CGC ATT TGC AAC CTC GAA GGC CGC GAT AT#C GCC CAC GGC GTC AGT     1008Ile Arg Ile Cys Asn Leu Glu Gly Arg Asp Il #e Ala His Gly Val Ser                325   #               330   #               335CGT TAC AAC AGC GAT GCA TTA CGC CGT ATT GC#C GGA CAC CAC TCG CAA     1056Arg Tyr Asn Ser Asp Ala Leu Arg Arg Ile Al #a Gly His His Ser Gln            340       #           345       #           350GAA ATT GAT GCA ATA CTG GGA TAT GAA TAC GG#C CCG GTT GCC GTT CAC     1104Glu Ile Asp Ala Ile Leu Gly Tyr Glu Tyr Gl #y Pro Val Ala Val His        355           #       360           #       365CGT GAT GAC ATG ATT ACC CGT        #                  #                1125 Arg Asp Asp Met Ile Thr Arg     370              #   375 (2) INFORMATION FOR SEQ ID NO:26:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 37 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:TATCGATAAG CTTATGCTGA CCCCGACCGA ACTGAAA       #                  #      37 (2) INFORMATION FOR SEQ ID NO:27:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 33 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:GGCAGAATTC TAGACGGGCT GGGCCAGCGC GAA        #                  #         33 (2) INFORMATION FOR SEQ ID NO:28:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 38 base  #pairs          (B) TYPE: nucleic acid           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:AAAATTGAAT TCCAGAGAAT CATGAGTGAC AGCCAGAC       #                  #     38 (2) INFORMATION FOR SEQ ID NO:29:     (i) SEQUENCE CHARACTERISTICS:           (A) LENGTH: 36 base  #pairs          (B) TYPE: nucleic acid.           (C) STRANDEDNESS: single          (D) TOPOLOGY: linear    (ii) MOLECULE TYPE: other nucleic acid,  #synthetic DNA    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:ACCCGGATCC ATTTACGCAC GAATGGTGTA ATCACC       #                  #       36

What is claimed is:
 1. A process for producingtrans-4-hydroxy-L-proline, which comprises steps of: (a) contactingL-proline with 2-ketoglutaric acid, a divalent iron ion and a source ofL-proline-4-hydroxylase activity wherein the source of said activity isselected from the group consisting of a microorganism, a culture of themicroorganism, lysed cells of the microorganism, and a purifiedL-proline-4-hydroxylase derived from the microorganism in an aqueousmedium to convert L-proline into trans-4-hydroxy-L-proline, and whereinthe microorganism is a microorganism selected from the group consistingof Streptomyces daghestanicus, a microorganism belonging to the genusDactylosporangium and a microorganism belonging to the genusAmycolatopsis; and (b) recovering the trans-4-hydroxy-L-proline from theaqueous medium.
 2. The process according to claim 1, wherein thecontacting is taken place during cultivation of a microorganism.
 3. Theprocess according to claim 1, wherein said source is anL-proline-4-hydroxylase having the following physicochemical properties:(1) Action and Substrate Specificity: The enzyme catalyzes hydroxylationof L-proline at the 4-position of L-proline in the presence of2-ketoglutaric acid and a divalent iron ion to producetrans-4-hydroxy-L-proline; (2) Optimum pH Range: The enzyme has anoptimum pH range of 6.0 to 7.0 for its reaction at 30° C. for 20minutes; (3) Stable pH Range: The enzyme is stable at pH values of 6.5to 10.0, when it is allowed to stand at 4° C. for 24 hours; (4) OptimumTemperature Range: The optimum temperature range is 30 to 40° C. when itis allowed to stand at pH 6.5 for 15 minutes; (5) Stable TemperatureRange: The enzyme is inactivated, when it is allowed to stand at pH 9.0and at 50° C. for 30 minutes; (6) Inhibitors: The enzyme is inhibited bymetal ions of Zn⁺⁺ and Cu⁺⁺ and ethylenediaminetetraacetic acid; (7)Activation: The enzyme does not need any cofactor for its activation.L-Ascorbic acid enhances the activity of the enzyme; (8) Km Value: Kmvalue is 0.27 mM for L-proline, when determined in an 80 mM2-(N-morpholino)ethanesulfonic acid (MES) buffer (pH 6.5) containing 8mM 2-ketoglutaric acid, 4 mM L-ascorbic acid, 2 mM ferrous sulfate and apre-determined amount of the enzyme at 30° C. for 20 minutes; Km valueis 0.55 mM for 2-ketoglutaric acid, when determined in an 80 mM2-(N-morpholino)ethanesulfonic acid (MES) buffer (pH 6.5) containing 4mM L-proline, 4 mM L-ascorbic acid, 2 mM ferrous sulfate and apre-determined amount of the enzyme at 30° C. for 20 minutes; (9)Molecular Weight: The enzyme has a molecular weight of 32,000±5,000daltons by sodium dodecylsulfate-polyacrylamide gel electrophoresis andof 43,800±5,000 daltons by gel filtration.
 4. The process according toclaim 3, wherein the L-proline-4-hydroxylase has the N-terminal aminoacid sequence of SEQ ID NO:
 1. 5. The process for producingtrans-4-hydroxy-L-proline according to claim 1, wherein themicroorganism is selected from the group consisting of cells, driedcells, lyophilized cells, surfactant-treated cells, solvent-treatedcells and immobilized cells.
 6. The process for producingtrans-4-hydroxy-L-proline according to claim 1, wherein the lysed cellsare selected from the group consisting of enzymatically-treated cells,ultrasonically-treated cells, mechanically-ground cells,mechanically-compressed cells and fractionated cell proteins.
 7. Theprocess for producing trans-4-hydroxy-L-proline according to claim 1,wherein the lysed cells of the microorganism are immobilized.
 8. Aprocess for producing an L-proline-4-hydroxylase, which comprises thesteps of: (a) cultivating a microorganism selected from the groupconsisting of Streptomyces daghestanicus, a microorganism belonging tothe genus Dactylosporangium, and a microorganism belonging to the genusAmycolatopsis so as to produce and accumulate theL-proline-4-hydroxylase in the culture, and (b) recovering theL-proline-4-hydroxylase therefrom.
 9. The process according to claim 8,wherein the microorganism is Dactylosporangium sp. RH1(FERM BP-4400) orAmycolatopsis sp. RH2(FERM BP-4581).